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ABSTRACT 	  	  
 
 
I. FORMAL SYNTHESIS OF CJ-12,954 AND CJ-13,014 USING 





II. SYNTHESIS AND INVESTIGATION OF DIASTEREOSELECTIVITY OF 




                                                                         by 
 
                                                 Yashoda Naga Deepthi Bhogadhi 
 




A formal synthesis of the natural products CJ-12,954 and CJ-13,014 was successfully 
accomplished using the zinc-mediated tandem chain extension-aldol reaction methodology. This 
chemistry was performed on a chiral β-keto imide synthesized using a DCC coupling reaction. 
The diastereoselectivity of the aldol reaction was controlled by an Evans chiral auxiliary. 
Comparison between the reported and experimental spectral data for the spiroketals confirmed 
the structural assignment. 
 The diastereoselectivity of the homologation-cyclization-rearrangement-lactonization 
reaction of β-keto imide derived from phenyl carbamate-protected proline was studied. Tetra-n-
butylammonium fluoride-mediated rearrangement of trimethylsilyl cyclopropanol demonstrated 
the role of chiral auxiliary and the amino acid stereocenter in controlling the diastereoselectivity 
of the bicyclic lactone formation.   
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CHAPTER I 	  
INTRODUCTION 	  	  
Carbenoid 
 The term ‘carbenoid’ was developed in the course of expanding new carbene precursors.1, 
2 A carbenoid is a synthetically useful version of a carbene that is stabilized by complexation to a 
metal.1, 2 Carbenoids can be divided into two classes. 
1) those of general structure MCH2X, M = Zn, Sm, Al etc. 
2) those that belong to structure M=CH2 
Organozinc carbenoids that possess sp3-hybridized carbon are an extensively studied class of 
carbenoids owing to their excellent reactivity and their ambiphilic nature.3 Organozinc 
carbenoids can act both as nucleophiles and electrophiles in reactions like addition to C-C double 
bonds, 1,2-alkyl(aryl) migrations etc.3 
Zinc carbenoids 
 The first zinc carbenoid (IZnCH2I) was prepared by Emschwiller in 1929,4 but this zinc 
carbenoid did not attract significant attention until Simmons and Smith reported in 1958 that this 
reagent could be used for the stereospecific conversion of alkenes to cyclopropanes.5, 6 The 
Simmons-Smith cyclopropanation reaction uses iodomethylzinc iodide (IZnCH2I), which is 
prepared by mixing a zinc/copper couple with CH2I2 in ether.5, 6 This reaction is widely used due 
to the stereospecificity with respect to the double bond geometry and its compatibility with a 
wide variety of functional groups.        
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  Variants of this versatile cyclopropanating reagent have been developed by 
replacing the iodide substituent bonded to the zinc atom with an alternate R group. Many of the 
variants are summarized in Figure 1.7 One of those carbenoids that is a more practical and 
reproducible cyclopropanation reagent is EtZnCH2I, which was developed by Furukawa in 1966 
by mixing equimolar amounts of readily available diethylzinc with CH2I2.8-10 This reaction was 
particularly useful for the cyclopropanation of cationically polymerizable olefins such as vinyl 
ethers. The Simmons-Smith reaction gave lower yields due to polymerization.  
 
 
Figure 1. Different types of carbenoids synthesized 
Zinc-mediated chain extension reaction 
Another application of the Furukawa carbenoid (EtZnCH2I) was not known until Brogan 
and Zercher in 1997 reported the one carbon homologation of β-keto esters to γ-keto esters.11 
This reaction was serendipitously discovered by Brogan and Zercher during an attempt to 
cyclopropanate the terminal olefins of ketal 1 (Scheme 1). Ketal 1, when subjected to Furukawa 
carbenoid EtZnCH2I, gave an unanticipated product 3, which contained both the cyclopropane 
and an additional methylene unit between the two carbonyls.  Similar methods have been 
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cyclopropane intermediate.12-16 However, the zinc-carbenoid-mediated homologation reaction, 
offers the advantages of being a mild, simple and efficient one-pot reaction.11   
 
	  
Scheme 1. Discovery of Zinc-mediated chain extension reaction 
 
 A variety of β-keto esters, β-diketones and α-substituted β-keto esters were subjected to 
the zinc-mediated chain extension conditions to elucidate the scope of the reaction.11 Several 
different β-keto esters 4a-i (Table 1), when subjected to 5 equivalents of zinc carbenoid, derived 
from diethylzinc and diiodomethane, rendered their respective γ-keto ester homologues 5a-i. All 
simple β-keto esters 4a-f proceeded cleanly and efficiently to their corresponding γ-keto ester 
homologues in high yields. Olefin-containing   β-keto esters 4g-h tolerated the chain extension 
conditions, thus affording their respective olefin-containing γ-keto ester homologues 5g-h. This 
result demonstrates that the chain extension reaction is more rapid than the cyclopropanation of 
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albeit in low yield and with the emergence of multiple byproducts. However, β-diketones 
behaved differently and will be discussed later in this chapter.   
 
	  
Table 1. Conversion of β-keto esters to γ-keto esters using chain extension reaction 
 
 The scope of the zinc-mediated chain extension reaction has been extended to variety of 
β-dicarbonyl substrates (Scheme 2).17 Some of those early substrates studied were β-keto 
phosphonates (6) (Scheme 2).18 γ-Keto phosphonates are present in molecules that possess 
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activity and this functionality could be obtained cleanly from the corresponding β-keto 
phosphonates in one step using the zinc carbenoid chain extension reaction. While β-keto esters 
undergo chain-extension in minutes, β-keto phosphonates required longer reaction times for 
chain extension.  
 
Scheme 2. Zinc-mediated homologation of variety of β-dicarbonyl substrate 
 
A wide variety of β-keto amides (7),20 including primary, secondary and tertiary amides 
were chain extended to their respective γ-keto amides in good yields. While β-keto tertiary 
amides provided products in good yields (42-88%), secondary and primary amides generated 



















































































	   6	  
extracting water-soluble products after aqueous work-up. Other substrates like β-keto imides 
(8),21-23 α-carboxyester imides (9)24, 25 and α-carboxydiimides (10)24 were studied and shown 
capable of undergoing zinc-mediated homologation (Scheme 2), thus broadening the scope of 
this reaction. 
Mechanism of zinc-mediated chain extension 
The mechanism of the zinc-mediated homologation reaction has been studied 
experimentally, including by NMR and computational studies (Scheme 3).26, 27  The proposed 
mechanism is described below. The methylene between the 1,3-dicarbonyl (16) is deprotonated 
either by an ethyl residue of diethylzinc or zinc carbenoid, resulting in the formation of zinc 
enolate 17. The enolate 17 then undergoes alkylation with a second equivalent of zinc carbenoid, 
resulting in the formation of homoenolate 18. An intramolecular cyclization of the homoenolate 
18 into the keto functionality generates a donor-acceptor cyclopropane intermediate 19 via path 
A, which undergoes fragmentation due to ring strain to provide organometallic intermediate 20, 
similar to a Reformatsky-type intermediate. Cyclopropane intermediate 19 was not observed in 
the NMR studies. The computational studies support the intramolecular methylene transfer via 
cyclopropane intermediate, and show that the cyclopropane fragmentation has a very low 
activation barrier, suggesting that if intermediate 19 is formed, it has a very short lifetime.26 The 
computational study also revealed an alternate mechanism for the formation of 20 via path B. 
This pathway does not include a donor-acceptor cyclopropane intermediate. Instead, the reaction 
proceeds via a 1,2-shift in which the homoenolate 18 is directly converted to Reformatsky type 
intermediate 20. The inclusion of solvation in the computational model resulted in the donor 
acceptor pathway being lower in energy than path B; therefore, path A appears likely to be the 
operative pathway in solution. 
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Scheme 3. Proposed mechanism for zinc-mediated homologation reaction supported both 
experimentally and computationally where R2 = ester, amide, phosphonates 
 
The Reformatsky-type intermediate 20, which contains anionic character at the position α 
to the ester, is considered as the resting state of the homologation reaction. Quenching with a 
mild acid like ammonium chloride gives the chain extended product 21. NMR studies by Aiken 
revealed the oligomeric nature of the C-bound zinc intermediate 20, which makes it less 
nucleophilic than a typical enolate; therefore, the zinc organometallic intermediate does not 
undergo alkylation with the excess carbenoid or the ethyl iodide present in the solution.27 The 
mechanism suggests that two equivalents of carbenoid are required; however, in practice three 
equivalents are used for a typical chain extension reaction to ensure that the reaction goes to 
completion. The presence of any other acidic hydrogen in the substrate, like an NH or OH, 
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Scheme 4. Formation of more reactive oxygen-bound zinc enolate in β-keto imides 
 
Slightly different product formation was observed in β-keto imide-derived systems 
(Scheme 4). The formation of α-methyl-γ-keto imide 25 as a byproduct during the chain 
extension of β-keto imides suggested a decreased stability of the organometallic intermediate.23, 
28, 29 Such a byproduct is proposed to arise from the alkylation of Reformatsky-type intermediate 
24 with the excess carbenoid in solution. This alkylation has not been observed in the case of β-
keto esters. In the case of the imide functionality, intermediate 23 could be in equilibrium with 
enolate 24 due to potential chelation of the zinc between the two oxygen atoms. Oxygen-bound 
zinc enolate 24, expected to be more reactive than carbon-bound zinc enolate 23, could undergo 
alkylation with the excess carbenoid, and provide the α-methyl-γ-keto imide 25 as the byproduct. 
The amount of α-methylated by-product can be reduced by careful control of carbenoid 
stoichiometry and reaction time. 
Zinc-mediated chain extension of β-diketones 
 β-Diketones behave differently in zinc-mediated chain extension conditions. In the 
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extension conditions resulted in the formation of γ-keto cyclopropanol 28 (Scheme 5).11 This 
product was produced by ring expansion followed by the rapid addition of the second methylene 
group. In a similar fashion, Xue and co-workers employed zinc carbenoid CF3CO2ZnCH2I for 




Scheme 5. Chain extension-cyclopropanation of β-diketones. 	  
 The proposed mechanism for the chain extension-cyclopropanation of β-diketones is 
similar to the one proposed for β-keto carbonyls, except that the zinc-enolate 34 reacts with a 
third equivalent of carbenoid to form the homoenolate 35 (Scheme 6). Homoenolate 35 
undergoes intramolecular cyclization to generate zinc cyclopropoxide 36, which on quenching 
with a mild acid generates the γ-keto cyclopropanol 37. The key to cyclopropanol formation is 
the high reactivity of the zinc-enolate equivalent (34). Heathcock has shown that zinc-ketone 
enolate possesses oxygen-bound zinc, which makes the reactivity very different from the 
Reformatsky-like ester organometallic intermediate.31 Chain extension-cyclopropanation 
reactions of β-diketones and β-keto carbonyls have been developed for the preparation of novel 
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Scheme 6. Proposed mechanism for the chain extension-cyclopropanation of β-diketones 
  
A novel γ-keto cyclopropanol rearrangement has also been studied on the cyclopropanols 
resulting from the chain extension of β-diketones.29, 32 Xue and co-workers reported that two 
isomeric γ-keto cyclopropanols were formed from homologation-cyclopropanation of β-
diketones that contains both aryl and aliphatic R groups.30 Based on results by Xue30 and 
Taschner29 of the Zercher group, it was hypothesized that rearrangement of product regioisomers 
might be occurring during the homologation-cyclopropanation reaction. When benzoylacetone 
was subjected to zinc carbenoid for a short time period, the product mixture had the aryl 
cyclopropanol as the major product and the methyl cyclopropanol as the minor product (Figure 
2).32 This major product would result from the preferential homoenolate 31 cyclization into the 
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carbenoid, equilibration to a thermodynamic mixture containing methyl cyclopropanol as the 
major isomer and aryl cyclopropanol as the minor isomer resulted. A zinc-chelated sigmatropic 
rearrangement (Figure 3) was proposed and computational studies by Moran provided support 
for the proposed rearrangement.33 Besides carbenoid, other organometallic bases like potassium 
tert-butoxide, sodium hydride, lithium diisopropylamide (LDA) and di-n-butyl magnesium have 
been successful in facilitating the rearrangement.34 
 
	  
Figure 2. Cyclopropanol rearrangement 
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Functionalization of β-position of the γ-keto backbone 
 Selective functionalization of α and β carbons (carbons 2 and 3) of 1,4-dicarbonyls by 
deprotonation followed by electrophilic addition is not practical due to the similarity in pKa’s of 
the α-protons adjacent to ketones, esters and amides. Zinc carbenoid-mediated chain extension 
reaction facilitates the incorporation of substituents at both of these positions either through the 
use of substituted carbenoids or by electrophile addition to the organometallic intermediate. As 
indicated from the proposed mechanism, the β-methylene of the homologated product arises 
from the insertion of zinc-carbenoid derived from 1,1-diiodomethane. On the basis of this 
knowledge, the β-position of the 1,4-dicarbonyl can be functionalized using a substituted 
carbenoid derived from gem-diiodoalkanes.  
1,1-Diiodoethane and α,α-diiodotoluene were employed as the substituted carbenoids in 
the chain reaction, which resulted in the formation of β-substituted γ-keto carbonyls (Table 2).35 
Several methods are available for the preparation of gem-diiodoalkanes.36, 37 1,1-Diiodoethane 
can be prepared by aluminum chloride-catalyzed reaction of 1,1-dichloroethane and ethyl 
iodide.38 An alternative method for the preparation of 1,1-diiodoethane is conversion of 
acetaldehyde to its corresponding hydrazone followed by treatment of iodine in the presence of 
triethylamine.39 α,α-Diiodotoluene can be prepared by subjecting benzaldehyde to 
trimethylsilyliodide.40 Synthesis of substituted cyclopropanes employing substituted carbenoids 
derived from gem-diiodoalkanes has been reported by other groups,41 whereas synthesis of 
substituted donor-acceptor cyclopropanes employing substituted carbenoid has only been 
explored by the Zercher group.35 β-Keto esters and amides were subjected to carbenoids 
generated from 1,1-diiodoethane to afford the corresponding β-methyl γ-keto esters or amides 
efficiently in one step via substituted donor-acceptor cyclopropane intermediate 39 (Table 2).35 
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While β-keto esters reacted with substituted carbenoid efficiently, β-keto amides were less 
efficient. In addition to the methyl group, attempts to substitute phenyl group at the β-position by 
employing α,α-diiodotoluene was successful, however this reaction was less efficient (Table 2). 
	  
Table 2. Conversion of β-keto esters and amides to β-substituted γ-keto substrates using    
methyl and phenyl substituted carbenoids. 
  
Functionalization of the β-position of 1,4-dicarbonyl generates a new stereocenter. 
Stereocontrol of this chiral center would broaden the scope of this reaction. Lin attempted to 
induce enantioselectivity in the reaction by employing a chiral ligand; however, these efforts 
resulted in the formation of a racemic mixture.23 Evans auxiliaries, which resulted in a good 
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stereocenter at the β-position. It was hypothesized that the establishment of an chiral 
environment around the ketone could influence the stereochemical course of the intramolecular 
cyclization that produces the substituted donor-acceptor cyclopropane. Chiral allylic and 
homoallylic alcohols have been shown to provide modest to good stereocontrol in carbenoid 
cyclopropanation reactions with the selectivity attributed to hydroxyl-directing effects.42 For 
instance, treatment of 3-cyclopentenol (41) with methyl-substituted zinc-carbenoid produced 
exo-6-methyl-cis-3-hydroxybicyclo[3.1.0]hexane (42) as the only isomer out of four possible 
isomers (Scheme 7).43 The mechanism of this reaction is proposed to involve complexation of 
the hydroxyl group with the zinc carbenoid, thereby facilitating stereoselective ethylidene 
transfer to the most accessible face of the alkene.43    
    
	  
Scheme 7. Homoallylic alcohol directed cyclopropanation using a methyl-substituted 
carbenoid 
 
The diastereoselective incorporation of the methyl-substituted zinc carbenoid in a chain 
extension reaction was probed by Mazzone, who studied reactions of L-serine-derived β-keto 
esters.44 It was proposed that the L-serine-derived β-keto ester 43 would generate intermediate 
44, which contains a homoallylic hydroxyl group (Scheme 8).44 Upon addition of carbenoid this 
homoallylic alcohol was anticipated to influence diastereoselectivity in the formation of 
substituted donor-acceptor cyclopropane 45. Fragmentation of the cyclopropane intermediate 45 
would retain the stereochemistry of the methyl substituent, whereas the other two cyclopropane 
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Mazzone studied the diastereomeric ratio of the β-methyl-γ-keto esters prepared from the 
use of a methyl-substituted carbenoid in the chain extension reaction of L-serine-derived β-keto 
esters (Table 3).44 Substrates 47a-c gave high diastereomeric ratios, whereas substrate 47e, 
which contained a cyclic five-membered ring, gave no diastereocontrol. Therefore, it was 
concluded that the hydroxyl functionality of the L-serine group can serve a crucial role in the 
high diastereocontrol observed during the zinc carbenoid-mediated chain extension reaction 
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Table 3. Diastereoselective synthesis of β-methyl γ-keto esters using an L-serine auxiliary 
 
Tandem chain extension protocols and their applications in natural product synthesis 
 Functionalization of the α-position of 1,4-dicarbonyls through deprotonation followed by 
electrophilic addition is not practical; however, zinc-mediated chain extension of a 1,3-
dicarbonyl generates a versatile organometallic intermediate 20, that has anionic character α to 
the ester, amide or imide. Various electrophiles like aldehydes,21 ketones,21 imines,45, 46 iminium 
ions, excess carbenoid,47 iodine,23, 28, 48 and anhydrides44, 45, 49 have been captured by the 
organometallic intermediate in a zinc-mediated tandem-chain extension reaction. In an effort to 
widen the scope of these tandem processes, methods for stereoselective functionalization of α-
position were also developed. Many of these tandem processes were implemented as a key step 
in the synthesis of natural products. The development and application of tandem chain extension 

















Entry Starting material R
1 R2 R3 dr
1 47a Boc BnH 20:1
2 47b Boc H TBDMS 20:1
3 47c Boc H MOM 15:1





	   17	  
Tandem chain extension-aldol reaction 
 The chain extension-aldol reaction was the first tandem protocol to be developed.21 The 
diastereoselectivity of the chain extension-aldol reaction was studied extensively. Chain 
extension-aldol reaction of β-keto esters and amides favored formation of the syn-isomer over 
the anti-isomer (Table 4). As mentioned earlier the zinc organometallic intermediate 20 is 
similar to the zinc-Reformatsky intermediate;50, 51 however, the high syn-selectivity of the zinc 
ester enolate was unprecedented. The lower reactivity of organometallic intermediate 20 
compared to a traditional enolate with respect to alkylation is believed to be due to the 
organometallic oligomeric nature;50, 51 however, addition of an aldehyde to this carbon-bonded 
zinc intermediate may be responsible to its isomerization to the more reactive oxygen-bonded 
zinc enolate.52 The O-bound enolate can exist in two geometries, Z-enolate 49 and E-enolate 50 
(Scheme 9). The ketone functionality in intermediate 20 is believed to play a vital role in 
favoring formation of the Z-enolate thus leading to the formation of syn-isomer with high 
diastereoselectivity via a closed (Zimmerman-Traxler) transition state (Table 4).53  
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Table 4. Tandem-chain extension aldol reaction of β-keto esters and amides 
 
A Zimmerman-Traxler model has been used to predict stereochemistry of aldol 
reactions that are believed to proceed through a closed chair-like transition state.53 If Z-
enolate 49 reacts with an aldehyde in a chair-like transition state (Scheme 10), the 
stereochemical outcome of the aldol reactions will be dictated by the facial selectivity of 
the aldehyde. When the R3 substituent of the aldehyde approaches the enolate in the 
pseudo-equatorial position 53, formation of the syn-isomer 55 would be predicted 
(Scheme 10); however, if the aldehyde approaches with the R3 substituent in the pseudo-
axial position 54, formation of the anti-isomer 56 could be predicted. In general, 
formation of anti-isomer 56 is less favored, which is rationalized by the undesired 1,3-
diaxial interactions in the transition state. The high diastereoselectivity of the tandem 
chain extension-aldol reaction of β-keto esters and amides favoring syn-aldol product 55 
suggests that the reaction proceeds via a Z-enolate in a chair-like transition state. 
R1 OR2
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Computational investigation also supported the assertion that the aldol reaction proceeds 
through a six-membered closed transition state.54 
	  
Scheme 10. Zimmerman-Traxler closed transition state model for the favored Z-enolate of 
the chain extension aldol reaction 
  
Tandem chain extension-aldol reactions (TCEA) involving β-keto imides (acylated Evans 
auxiliaries) also have been studied. The diastereoselectivity of this reaction favors formation of 
the anti-isomer over the syn-isomer.55 The formation of anti-isomer as the major product can be 
rationalized by the Heathcock open-transition state model.56 The presence of excess Lewis acid 
and an extra Lewis basic site on the oxazolidinone is proposed as necessary for the reaction to 
proceed through an open-transition state, where one equivalent of Lewis acid chelates to the two 
imide carbonyls and the other equivalent of Lewis acid activates the aldehyde. The carbon-bound 
zinc organometallic (57) may be in equilibrium with two enolate isomers, however the Z-enolate 
58 is favored over the E-enolate 59 due to the absence of undesired A1,3 strain observed with the 
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Scheme 11. Z- and E- Geometries for the imide enolate 
 
 The diastereoselectivity in tandem chain extension-aldol reactions of β-keto imides is 
also dictated by the facial approach of the aldehyde in the open transition state. If the Z-enolate 
attacks on the face of the aldehyde where the steric interactions are minimized as in the transition 
state 61, anti-isomer 63 is formed.55 If attack of the Z-enolate takes place on the opposite face of 
the aldehyde, where steric interactions between R group of the aldehyde and the imide are 
maximized as in transition state 60, syn-isomer 62 is formed (Scheme 12).  
 
	  
Scheme 12. Open transition state for tandem chain extension-aldol of β-keto imide 	  
 The analysis of the diastereomeric ratio of products generated in the tandem chain 
extension-aldol reactions is often difficult to analyze by NMR due to the equilibrium existing 
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equilibrium with their hemiketals (Scheme 13). The syn-aldol 55 exists in equilibrium with 
hemiketal 64 where the substituents R2 and the ester functionality are trans to each other. The 
product exists mostly in the hemiketal form. The anti-aldol 56 also exists in equilibrium with 
hemiketal 66, however the substituents R2 and the ester groups are cis to each other in the 
hemiacetal form. A greater proportion of the open form is observed for the anti-aldol isomer. 
This equilibrium provides the means by which the closed forms can be converted to a spiroketal 
framework through acid mediated cyclization. This methodology was key to the formal synthesis 
of spiroketal-based natural products CJ-12,954 and CJ-13,014 ,which will be discussed in detail 
in Chapter II.     
 
	  
Scheme 13. Equilibrium between open chain and closed hemiketal isomers. 
CAN-mediated oxidative cleavage of hemiacetals 
During an attempt to remove a para-methoxybenzyl (Pmb) protecting group, Lin 
serendipitously discovered a ceric ammonium nitrate (CAN)-mediated oxidative cleavage of 
hemiacetals that results in formation of substituted γ-lactones.23 The reaction requires the 
presence of a heteroatom vicinal to the hemiacetal hydroxyl group. Complexation of the 
hydroxyl group of the hemiacetal 68 derived from the tandem chain extension-aldol reaction 
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carbon bond, which affords the corresponding γ-lactone 70 (Scheme 14). The proposed 
mechanism predicts that the stereocenters established during the TCEA reaction would not be 
impacted during the cleavage process, which was also confirmed experimentally with no 
epimerization of those stereocenters being observed. Jacobine employed both the TCEA reaction 
and CAN-mediated oxidative cleavage methodologies to access the paraconic acid family of 
natural products (Scheme 15).45, 58  
 
	  
Scheme 14. CAN-mediated oxidative cleavage of hemiacetal to γ-lactone 
 
	  
Scheme 15. Synthesis of 3,4,5-trisubstituted γ-lactone by TCEA reaction and CAN-mediated 
oxidative cleavage 
 
Tandem chain extension-oxidation-elimination reaction 
 A rapid one-pot conversion of β-keto carbonyls to the corresponding α,β-unsaturated γ-
keto carbonyls employing sequential chain extension-oxidation-elimination was developed.48 
The organometallic intermediate 20 was trapped with iodine to generate the corresponding α-
halogenated γ-keto carbonyl, which was then treated with a base (DBU was used frequently) to 
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also tolerated this reaction. Amino acid substrates afforded the corresponding α,β-unsaturated 
products, although epimerization of the stereocenter took place. This method was successfully 
employed in the formal syntheses of 16-membered dilactone natural product (-)-pyrenophorin48 
and in the formal synthesis of (+)-brefeldin A (79)23 (Scheme 16).  
 
	  
Scheme 16. Formal synthesis of (+)-Brefeldin A 
  
The tandem chain extension-oxidation-elimination reaction has also been key to the total 
syntheses of macrocyclic β-keto lactones (+)-patulolide A and (-)-patulolide B (Scheme 17).59 
The stereochemistry of alkenes was controlled by use of kinetic and thermodynamic conditions 
in the elimination reaction. Use of excess base followed by stirring the reaction mixture at room 
temperature resulted in formation of the Z-olefin in (-)-patulolide B, whereas using one 
equivalent of base at lower temperature (-15 oC) resulted in E-olefin in (+)-patulolide A.59 
Whereas chain extension was sluggish in these macrocyclic systems, change of solvent from 
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Scheme 17. Total synthesis of patulolide A and B using chain-extension-oxidation-
elimination reaction 	   	  
Tandem chain extension-Mannich reaction 
 
 One of the more recently developed tandem protocols involves the use of activated 
imines for the capture of organometallic intermediate 20.46 Jacobine developed the tandem chain 
extension-Mannich reaction as a novel method to synthesize β-proline derivatives. The 
organometallic intermediate generated from the chain extension was trapped with N-
phosphinoylimine 82 to generate the respective β-amino acid 83, which was deprotected and 
reduced to afford β-proline derivative 84 (Scheme 18).46 The efficiency and yield of the tandem 
chain extension-Mannich reaction was improved by changing from phosphinoyl imines to Boc-
activated aryl imines. Trifluoroacetic acid-mediated Boc-deprotection followed by reductive 
cyclization using sodium cyanoborohydride rendered the β-proline derivatives in good yields 
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extension-imine capture reaction. While the Mannich reaction with the phosphinoyl imines gave 
syn-aldol like stereochemistry, the Boc-protected imines favored formation of “anti-aldol” β-
amino esters. The tandem chain extension-Mannich reaction of chiral β-keto imides gave β-
proline derivatives with absolute stereocontrol. The tandem chain extension-Mannich reaction 
using sulfone-activated imines is currently under investigation.60  
 
	  




Scheme 19. Tandem chain extension-imine capture reaction with Boc-activated imines 
 
 
 α-Methylation of γ-keto carbonyl 
 Synthesis of α-methylated γ-keto esters by trapping the zinc organometallic intermediate 
20 with alkyl halides like methyl iodide or methyl bromide cannot be achieved due to the 
reduced nucleophilicity of 20 compared to a traditional enolate. However, indirect methylation 
can be achieved by addition of trimethylsilylchloride (TMSCl) in the presence of excess 
carbenoid. Addition of TMSCl is believed to promote the fragmentation of the dimeric 
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Reformatsky-type intermediate 88 (Scheme 20),20, 47, 61 which results in the formation of a 
nucleophilic species like 89a or 89b. Capture of the excess carbenoid by these nucleophiles 
generates homoenolate 90, which may be quenched with a mild acid to form α-methylated γ-keto 
carbonyl47, 61 or with iodine to form α-iodomethylated γ-keto carbonyl.28 Synthesis of α-
iodomethylated γ-keto carbonyls provided opportunities for both cross coupling reactions and 
nucleophilic displacement of the iodine, both of which can lead to diversification of the 
substitution pattern of the γ-keto carbonyl. 
 
	  
Scheme 20. Synthesis of α-methylated and α-iodomethylated γ-keto ester 
Tandem Chain Extension-Acylation Reaction  
  The scope of the zinc-mediated chain extension reaction was broadened when Jacobine 
reported the synthesis of α-acylated γ-keto ester 93 by trapping the zinc organometallic 
intermediate 20 with acetic anhydride (Scheme 21).45 Taddei and co-workers synthesized a 
similar α-acylated γ-keto ester by subjecting the aldol product derived from tandem chain 
extension homologation-aldol reaction to PCC oxidation.62 Synthesis of highly functionalized 
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Knorr synthesis enhances the potential utility of the tandem chain extension-acylation reaction 
(Scheme 22). Mazzone used cyclic anhydrides as acylating agents to synthesize spiroketals,44 
which are found in many natural products.63 Mazzone employed this methodology to target the 
papyracillic acid family of natural products.64 The spiroketal framework of 4-epi-papyracillic 
acid B (99) and Papyracillic acid B (100) was synthesized in one step by exposing methyl 
acetoacetate (96) to ethyl(iodomethyl)zinc and then trapping the organometallic intermediate 
with methoxymaleic anhydride (97) (Scheme 23).64 A similar approach was employed by 
Spencer recently in the synthesis of papyracillic acid A.49 
 
	  
Scheme 21. First reported synthesis of α-acylated γ-keto ester 
 
	  
Scheme 22. Paal-Knorr synthesis of highly functionalized heterocycles 
  
 Spencer subjected various β-keto esters to diverse anhydrides in a study designed to 
understand the scope of tandem chain extension-acylation reaction (Table 5).49 These studies 
determined that the presence of bulky or aromatic substituents49 on the ketone or ester 
functionalities do not decrease the efficiency of the reaction.  
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Scheme 23. One-pot synthesis of spiroketal framework of Papyracillic acid B using tandem 
chain extension-acylation reaction 
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Table 5. Scope of tandem chain extension-acylation reaction 
Summary 
Development of the zinc-mediated chain extension reaction provides a facile method for 
the synthesis of γ-keto carbonyls. The versatile zinc organometallic intermediate generated 
during the chain extension reaction can be trapped with various electrophiles, thus opening new 
avenues for the various tandem processes discussed above. The diastereoselectivity in many 
tandem processes, like the aldol, Mannich and iodination-elimination reaction was also 
controlled efficiently. Application of this versatile zinc-mediated chain extension reaction to 

















Starting material R1 R2 R3 Product Yield (%)
81 t-Bu OMe Me 101 63
81 t-Bu i-Pr 102 80OMe
81 t-Bu OMe Ph 103 95
104 Me O Me 105 36
104 Me O Ph 106 51
107 Me OAllyl Me 108 44
107 Me OAllyl Ph 109 73
110 Ph OMe Me 111 55
110 Ph OMe Ph 112 51




O Ph 116 80




FORMAL SYNTHESIS OF CJ-12,954 AND CJ-13,014 USING ZINC-
MEDIATED TANDEM CHAIN EXTENSION-ALDOL REACTION 
 
Basic Ring-Systems of Spiroketal  
 
 Spiroketals occur as the main backbone in many natural products with pharmacological 
activity. Different ring arrangements of spiroketals exist, however, three different types are 
predominantly found.63 They are ring systems A, B and C (Figure 4). The ring system A is 1,7-
dioxaspiro[5.5]undecane 117, which consists of two six membered rings fused at carbon 6. The 
ring system B is 1,6-dioxaspiro[4.5]decane 118, which consists of a six and five membered rings 
fused at carbon 5. The ring system C is 1,6-dioxaspiro[4.5]decane 119, which consists of two 
five membered rings fused at carbon 5. 
 
	  
Figure 4. The A, B and C Ring Systems of Spiroketals. 
Spiroketals are obtained from many sources including insects, microbes, plants, fungi and 
marine organisms. The biological activity of spiroketal-based natural products and also the role 
of spiroketals in protecting group chemistry65, 66 has been extensively studied. Many novel and 
flexible approaches have been designed for the synthesis of spiroketal frameworks.67-69 The 








































	   31	  
Configuration and Stereochemistry in Spiroketal  
Four all-chair conformers are available for the spiro[5.5] ring systems (Figure 5).70 
However, the one where the individual C-O bonds of the O-C-O bonding system are positioned 
axially relative to the ring unit to which they are connected is the most thermodynamically-
favored conformer of the spiroketal. This stability has been ascribed to the anomeric effect, 
which outweighs the more sterically favored equatorial orientation (Figure 6). The anomeric 
effect is the stabilizing overlap between the oxygen lone-pair orbital with the exocyclic C-O 
bonds constituting the O-C-O bonding system, and the stabilization is maximized when the two 
are positioned antiperiplanar to one another allowing for optimal overlap.71 The anomeric effect 
has been extensively studied in spiro[5.5] ring systems, whereas this effect is less consistent and 
predictable in spiro[4.5] and spiro[4.4] ring systems due to lack of well-defined axial or 
equatorial positions in five-membered rings.72 
 
	  
Figure 5. Conformation in Spiroketals 
 
	  
Figure 6.  The Anomeric Effect in Spiroketals 
Cyclization of dihydroxyketones is one of the most commonly employed synthetic 
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120 as the key intermediate, which loses water to form oxocarbenium ion followed by attack of 
the other alcohol to access the spiroketal framework. The tandem chain extension aldol reaction 
(TCEA) as discussed in Chapter 1 was the first tandem chain extension protocol developed. 
The aldol products from tandem chain extension-aldol reaction (TCEA) exist in both the open 
chain form and its hemiacetal (Scheme 25). Hence the TCEA reaction can provide easy access to 
the hemiacetal 123, which is key intermediate in spiroketal synthesis.       
	  
Scheme 24. Synthesis of spiroketal by cyclization of dihydroxy ketone. 
 
	  
Scheme 25. Proposed Application of TCEA reaction in the synthesis of spiroketals via           
hemiacetal intermediate 
CJ-12,954 and Its Congeners – New Anti-Helicobacter pylori Agents 
 In a screening program to discover safe and effective compounds having excellent anti-
Helicobacter pylori activity Dekker et al. extracted seven phthalide compounds 126a-g (Figure 
7) from the basidiomycete Phanerochaete velutina.73 Helicobacter pylori, a Gram-negative 
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Current treatment methods employ one or two broad spectrum antibiotics combined with a 
proton pump inhibitor or a bismuth salt.75 Prolonged course of therapy is required for complete 
eradication of H.pylori related infections.76 However, long-term treatment in these patients can 
result in side-effects due to toxic bismuth salts and also build-up of drug resistance due to the use 
of antibiotics. Hence, compounds with specific anti-H.pylori activity, but that are inactive against 
other Gram-positive and –negative bacteria, are highly desired. Hence, in the early stage of their 
screening program Dekker et al. eliminated other extracts having antibacterial activity which can 
be obtained by common antibiotics.73 The phthalide compounds were found to be effective only 
against Helicobacter pylori and showed no antimicrobial activity against other microorganisms 
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Figure 7. Structures and helicobactericidal activities of phthalides 126a-g. 
 
Dekker et al. elucidated the structures of the seven phthalide extracts including CJ-12,954 
(126a) and CJ-13,014 (126b) using 1H NMR, 13C NMR, COSY, NOE difference, DEPT and 
HREI-MS data. CJ-12,954 (126a) contains a 5,5-spiroacetal ring joined through a polymethylene 
chain to the phthalide unit. CJ-13,014 (126b) was identified to be an isomer of 126a and has the 
same planar structure by all spectroscopic methods. Hence CJ-13,014 was identified as the 
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13,014 (126b) were also confirmed by the comparison of their spectral data with the structurally 
related helicobactericidal compounds spirolaxine 127 and its methyl ether 128, which also 
contains a 6,5-spiroacetal ring joined through a polymethylene chain to a phthalide unit (Figure 
8).77 Whilst Dekker et al. assigned the relative stereochemistry of the three stereogenic centers on 
spiroketal ring of (126a) and (126b), they were unable to elucidate the absolute stereochemistry 
of the four stereocenters of the natural products CJ-12,954 (126a) and CJ-13,014 (126b).  
 
	  
Figure 8. Helicobactericidal compounds Spirolaxine 
 
Based on the antimicrobial assay, it was observed that the helicobactericidal activities of 
the phthalide compounds strongly depend on their structures (Figure 7). Among the seven 
phthalide extracts, the spiroketal-containing CJ-12,954 (126a) and CJ-13,014 (126b) were found 
to be the two most potent anti-Helicobacter pylori agents.73 While the change in stereochemistry 
of the spiroketal backbone has no effect on antibacterial activity, the ring opening of spiroketal to 
γ-diketone 126c reduced the potency by 100-fold. This supports the significance of spiroketal 
framework towards helicobactericidal activity. Hence these spiroketal-containing phthalide 
compounds, CJ-12,954 (126a) and CJ-13,014 (126b) can be considered as potential new leads 
for the treatment of H. pylori related diseases. 
 The total synthesis of (±)-CJ-13,015 (126c), one among the seven phthalide-
extracts was first reported by Argade and Mondal.78 The total synthesis was accomplished in six 







Spirolaxine 127: R = H Spirolaxine methyl ether 128: R = Me
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necessary to synthesize the other structurally similar compounds of the series. Brimble et al. later 
reported the racemic total syntheses of five of the Phanerochaete. velutina series of phthalide 
antibiotics 126c-g (Scheme 26a,b).79 The indole analogues of these anti-Helicobacter pylori 
compounds were also synthesized.80   
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Scheme 27b. Retrosynthetic analysis of CJ-13,015, CJ-13,102, CJ-13,103, CJ-13,104 and 
CJ-13,108 
First Reported Synthesis of ent-CJ-12,954 and ent-CJ-13,014 
 Brimble et al. in 2006 first reported the enantioselective total syntheses of the spiroacetal-
containing helicobactericidal antibiotics CJ-12,954 (126a) and CJ-13,014 (126b).81 The 
spiroketal backbone of ent-CJ-12,954 (141) and ent-CJ-13,014 (142) was synthesized by 
deprotection followed by spirocyclization of diprotected dihydroxy ketone 133 which resulted an 
inseparable 1 : 1 mixture of spiroketals 134 and 135 (Scheme 27).81, 82 The key step in their total 
syntheses involves convergent union of 1:1 mixture of heterocycle-activated spiroketal sulfones 
136 and 137 with (3S)-phthalide aldehyde 138 (Scheme 28). Hydrogenation of the mixture of 
alkenes 139 and 140 afforded an inseparable 1 : 1 mixture of ent-CJ-12,954 (141) and ent-CJ-
13,014 (142).82 The presence of the 5,5-spiroacetal ring was confirmed by characteristic 
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Brimble et al. targeted the synthesis of the natural products CJ-12954 (126a) and its 
epimer CJ-13,014 (126b); however, on comparison of their 1H and 13C NMR data, optical 
rotations and HPLC retention times with the pure samples of the natural products obtained from 
Pfizer Inc., they established that their synthetic isomers 141 and 142 are enantiomers of the 
natural products.82 Subsequent to the establishment of the absolute stereochemistry of the natural 
products CJ-12,954 (126a) and CJ-13,014 (126b) we have attempted the formal synthesis of 
these natural products employing zinc-mediated tandem chain extension aldol methodology. The 
goals of our formal synthesis were to make the correct isomer, which can be used to test the 
scope of chain extension methodology and to perform the synthesis more efficiently. All our 
attempts towards the synthesis are explained in this chapter. 
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Scheme 29. Brimble et al. approach towards the total synthesis of ent-CJ-12,954 and ent-CJ-
13,014. 
Aiken’s attempts towards the synthesis of CJ-12,954 
 Karelle Aiken of the Zercher group has reported efforts to synthesize natural product CJ-
12,954 (126a) employing zinc-mediated tandem chain extension as the key methodology.27 
Aiken attempted two different approaches for the synthesis of CJ-12,954. When Aiken initiated 
her efforts towards the total synthesis of CJ-12,954, the absolute stereochemistry of neither the 
phthalide unit nor the spiroketal were known. Only the relative stereochemistry of the spiroketal 
backbone had been determined by Dekker et al.73 Since the absolute stereochemistry of the 
natural product CJ-12,954 was unknown, Aiken’s efforts were directed towards the total 
syntheses of the natural product and to the establishment of the absolute stereochemistry of the 
natural product. The first synthetic approach involved a palladium-mediated coupling reaction 
between phthalide unit 143 and a spiroketal unit 144 (Scheme 29). The spiroketal 144 needed for 
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TMS-propynal 145 and β-keto ester 146, followed by deprotection and decarboxylation. The 
phthalide unit 143 needed for palladium coupling was proposed to be synthesized from a Diels 
Alder reaction between a 2,4-dimethoxyfuran (147) and an α,β-unsaturated γ-keto ester 148, 
which can be accessed from the tandem chain extension-oxidation-elimination reaction (Scheme 
29). However Aiken’s attempts towards the synthesis of desired 2,4-dimethoxyfuran (147) were 
unsuccessful. Hence a different approach was designed for the synthesis of CJ-12,954 (126a). 
 As mentioned earlier the TCEA reaction of a hydroxy β-keto ester 121 was proposed as a 
means to access the key spiroketal framework. Hence Aiken’s second synthetic approach 
proposed that CJ-12,954 (126a) could be accessed by a TCEA reaction between a phthalide 
aldehyde 150 and a TBDPS-protected hydroxy β-keto ester 149, followed by TBDPS-
deprotection, an ester hydrolysis and Barton decarboxylation (Scheme 30). While Aiken’s 
efforts towards the synthesis of spiroketal unit employing TCEA reaction were successful, the 
absolute stereochemistry of the natural product was unknown until 2006, when Brimble et al.  
established the absolute stereochemistry of the natural products CJ-12,954 and CJ-13,014.81 The 
anticipated stereochemistry of the Aiken synthesis was diastereomeric to the natural product 
stereochemistry. Furthermore, the efficiency of the synthetic effort could be improved, which led 
to the second generation approach discussed in this thesis. 
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Scheme 30. Aiken’s first synthetic approach towards the synthesis of CJ-12,954. 
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Efforts towards the formal synthesis of CJ-12,954 and CJ-13,014  
 The zinc-mediated tandem chain extension aldol (TCEA) reaction was employed 
as the key step towards the formal synthesis of CJ-12,954 (126a). Spiroacetals 134 and 135 
(Figure 9) were the advanced intermediates synthesized by Brimble et al. which were eventually 
converted to the enantiomers of the natural products ent-CJ-12,954 (141) and ent-CJ-13,014 
(142) respectively.81, 82 In the Brimble syntheses spirocyclization of protected dihydroxy ketone 
133 using camphorsulfonic acid afforded inseparable 1:1 mixture of spiroacetals 134 and 135 
(Scheme 31); however, total synthesis of the natural products CJ-12,954 (126a) and CJ-13,014 
(126b) has not been reported to date. Hence, formal synthesis of the advanced intermediates 151 
and 152 (Figure 10) with the natural stereochemistry as the natural products CJ-12,954 and CJ-
13,014 was attempted using TCEA as the key methodology. Thus it was proposed that these 
advanced intermediates could be converted to natural products using the synthetic strategy 
followed by Brimble et al. with minor modifications. 
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        Scheme 32. Brimble et al. approach towards synthesis of spiroacetals 34 and 35 
 
	  
Figure 10.  Targeted spiroacetals 151 and 152 for formal synthesis 
First Synthetic Approach Towards Spiroacetal Backbone 
 The initial attempt towards the formal synthesis involved the targeting of spiroacetal 
alcohol 153, which would come from cleavage of the tert-butyldimethylsilyl ether 154 with 
tetrabutylammonium fluoride as illustrated in the retrosynthetic analysis (Scheme 32). The silyl 
ether 154 would come from Barton decarboxylation of spiroketal carboxylic acid 155. The 
hydrolysis of imide carbonyl functionality of 156 would give carboxylic acid 155. Acid-
mediated spirocyclization followed by dehydration of the hemiacetal 157 would afford spiroketal 
156. The zinc-mediated chain extension of β-keto imide 159 derived from an Evans chiral 
auxiliary would give the chain extended aldol product 158 which exists in equilibrium with its 
closed form hemiacetal 157. Thus the tandem chain extension-aldol reaction offers a novel 
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Scheme 33. Retrosynthetic scheme for the synthesis of spiroacetal 153 
Attempts towards the synthesis of β-keto imide 159 
 β-Keto imide 159 is the key intermediate required for the synthesis of spiroacetal 153. β-
Keto imide substrates that incorporate the Evans chiral auxiliary, when subjected to TCEA 
reaction, favor formation of the anti aldol-isomer over syn aldol-isomer.21 The aldol component 
of the TCEA reaction of a β-keto imide is believed to proceed through an open transition state as 
discussed in Chapter 1. Based on the synthetic approach, stereochemistry of the carboxylic acid 
side chain (C-3) was not relevant to the final product; however the anti-aldol isomer was targeted 
in order to establish the C-2 stereocenter. Hence, the stereochemistry of the β-keto imide starting 
material was chosen to control the necessary anti-selective aldol TCEA reaction that would 












































	   45	  
to induce asymmetry into the TCEA reaction using the chiral auxiliary D-camphorsultam (160) 
(Figure 11). However, the desired stereochemistry could not be established with D-
camphorsultam; therefore, the chiral auxiliary employed in the synthetic effort described below 
was the Evans chiral auxiliary 161 derived from L-phenylalanine (162) (Figure 11). 
 
                                                        	  
Figure 11. D-camphorsultam and Evans chiral auxiliary 
 Chiral-2-oxazolidinones, also known as Evans chiral auxiliaries, are versatile chiral 
auxiliaries with broad application in asymmetric synthesis.83-87 Evans chiral auxiliary 161 was 
synthesized from L-phenylalanine (162) following the method developed by Wu and Shen 
(Scheme 33).88 L-Phenylalanine (162) was reduced with LiAlH4 to amino alcohol 163 which 
was then treated with ethyl chloroformate to give carbamate 164. The carbamate 164 was then 
cyclized on heating in the presence of potassium carbonate under vacuum to afford the chiral-2-
oxazolidinone 161 in 52% yield. This chiral oxazolidinone was then reacted with acetylated 
Meldrum’s acid 166 in refluxing toluene to afford the β-keto imide 167 (Scheme 34), which was 
further used in the preparation of hydroxy-substituted β-keto imide 159. The dianion of the β-
keto imide 167 was formed by treating 167 with 1.1 equiv of sodium hydride followed by 2.5 
equiv of n-butyllithium (Scheme 35). The generation of a dianion of β-keto imide 167, indicated 
by the deep orange reaction mixture, was treated with racemic propylene oxide in an effort to 
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equilibrium with hemiacetal 168. However, the 1H and 13C NMR of the crude reaction mixture 
did not show any evidence of the product.   
Scheme	  34.	  	  Synthesis	  of	  Evans	  chiral	  auxiliary	  from	  L-­‐phenylalanine	  
	  
Scheme 35. Synthesis of β-keto imide 167 
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An alternative attempt to synthesize hydroxy-substituted β-keto imide 159 made use of a 
mixed-Claisen reaction (Scheme 36). Chiral oxazolidinone 161 was refluxed with acetyl chloride 
in pyridine to yield acylated chiral oxazolidinone 169. Acylated chiral oxazolidinone 169 was 
treated with Lithium diisopropylamine (LDA) in THF at -78 oC to form the corresponding 
lithium enolate. The lithium enolate was treated with γ-valerolactone to yield the hydroxy-
substituted β-keto imide 159. Once again, the 1H and 13C NMR of the crude reaction mixture did 
not show evidence of the desired product. 
	  
Scheme 37. Failed synthesis of β-keto imide 159 via mixed-Claisen route 
DCC Coupling Route for the Synthesis of β-Keto imide 175  
  An alternative and ultimately successful method for the synthesis of hydroxy-
protected β-keto imide 175 was based upon a DCC-mediated condensation reaction (Scheme 
37). The reaction was first attempted with racemic γ-valerolactone 170 to test the feasibility of 
the reaction. Racemic γ-valerolactone 170 was saponified with sodium hydroxide, then 
diprotected with tert-butyldimethylsilane to form the corresponding bis-TBDMS derivative 
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acid 172.90 Carboxylic acid 172 was then subjected to DCC, Meldrum’s acid and 4-
dimethylaminopyridine in dichloromethane to yield the corresponding stable 4-
dimethylaminopyridine (DMAP) salt 173 in 94 % yield (Scheme 37).91 Removal of DMAP salt 
with aqueous acid followed by solvent extraction and evaporation can lead to product 
decomposition, therefore the non-aqueous protocol developed by Raillard and co-workers was 
followed.91 The DMAP salt 173 was dissolved in dichloromethane and stirred with DOWEX 
50W-X2 resin (a polystyrene based sulfonic acid, an acidic H+ cation exchanger) to afford the 
respective free acid 174.91 The free acid 174 is an unstable oil, which, without any further 
purification, was refluxed with chiral oxazolidinone 161 in toluene to afford the desired hydroxy-
protected β-keto imide 175 as a 1:1 mixture of diastereomers in 45% yield after purification. The 
1H NMR of the β-keto imide 175 showed the characteristic AB of the diastereotopic methylene 
protons. However the hydroxy protected β-keto imide 175 does not exist in equilibrium with its 
hemiacetal form as in the case of hydroxy substituted β-keto imide 159 due to the TBDMS 
protection in 175.   
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Tandem Chain Extension Aldol Reaction (TCEA): 
 The zinc-mediated tandem chain extension-aldol reaction (TCEA) is the key step 
designed to synthesize the spiroketal framework of the natural products CJ-12,954 and CJ-
13,014. As discussed in Chapter I the reactivity and diastereoselectivity of TCEA of β-keto 
esters, amides and imides were extensively studied.  In contrast to β-keto esters and amides, β-
keto imides give more side products under zinc carbenoid-mediated chain extension reactions. β-
Keto imide 175 was subjected to tandem chain extension-aldol reaction using aldehyde 176 to 
study the feasibility of the reaction (Scheme 38). Aldehyde 176 was synthesized by 
monosilylation of 1,4-butanediol (179) followed by PCC oxidation (Scheme 38).92, 93 In an initial 
attempt β-keto imide 175 was added to the preformed carbenoid, stirred for 30 min to allow for 
chain extension followed by addition of aldehyde 176. The TCEA reaction involving β-keto 
imide 175, which exists as a mixture of diastereomers, with aldehyde 176 was proposed to give 
the aldol product 177, which in turn would exist in equilibrium with its hemiacetal 178 (Scheme 
38). The 1H NMR of the crude reaction mixture was difficult to analyze for the presence of 
TCEA product due to the presence of diastereomeric open-chain and hemiacetal forms. 
However, the presence of tandem chain extension-aldol product in the crude reaction mixture 
was confirmed by the 13C NMR spectroscopy signal of the hemiacetal carbon in CDCl3. Four 
different signals in the range δ 110-113 ppm corresponding to four different hemiacetal carbons 
were observed. Based on these initial results, it was confirmed that application of TCEA reaction 
of the β-keto imide 175 for the synthesis of the spiroketal backbone is feasible. However, since 
β-keto imide 175 had been derived from the racemic γ-valerolactone 170, a mixture of 
diastereomeric products were generated. Future attempts were focused on the synthesis and 
utilization of desired enantiopure  (R)-γ valerolactone (181). 
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Scheme 39. TCEA reaction of β-keto imide 175 derived from racemic γ-valerolactone 170 
 
	  
Scheme 40. Synthesis of aldehyde 176 
Synthesis of (R)-γ-Valerolactone 
 The C-7 stereocenter (Figure 10) in the targeted spiroketals 151 and 152 has R 
stereochemistry. As illustrated in the retrosynthetic analysis, this stereocenter comes from the γ- 
carbon next to the keto functionality in   β-keto imide 175, which ultimately is derived from the 
γ- carbon of the γ-valerolactone  (Figure 12). Since R stereochemistry is desired, (R)-γ- 
valerolactone (181) is the necessary starting material for the synthesis of β-keto imide 194, 
which would be the substrate for the tandem chain extension aldol reaction. Hence formal 
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Figure 12. Establishing C-7 stereocenter in 151 and 152 from (R)-γ-valerolactone 
  
Attempts to synthesize enantiopure (R)-γ-valerolactone (181) involved following the 
literature protocol reported by Brown et al.94 Optically pure diisocamphenylborane (Ipc2BH) 
(183) was synthesized from commercially available (+)-α-pinene (182) (91% ee) and borane-
methyl sulfide (BMS) by asymmetric hydroboration (Scheme 40).94 Asymmetric reduction of the 
keto acid 184 with Ipc2BH 183 yielded the hydroxy acid 185, although in very low yield 
(Scheme 40).95 Attempts to increase the yield of the reaction were unsuccessful. Efforts to 
lactonize the hydroxy acid 185 to the corresponding (R)-γ valerolactone (181) through treatment 






































	   52	  
	  
Scheme 41. Attempted synthesis of (R)-γ-valerolactone (181) using Ipc2BH (182) 
 
An alternative approach for the synthesis of (R)-γ-valerolactone (181) involved the use of 
a chiral epoxide.96 The condensation of dimethyl malonate (186) with commercially available 
(R)-propylene oxide (187) with 99% ee gave lactone ester 188, which upon Krapcho 
decarboxylation afforded the desired (R)-γ-valerolactone (181) in 40% yield (Scheme 41).96 An 
optical rotation was obtained for (R)-γ-valerolactone (181) and was calculated to be [α]D20 +24.8o 
(c 0.23, CH2Cl2), which was compared to literature +31.4o (c 1, CH2Cl2). A positive specific 
rotation correlates to (+)-(R)-γ-valerolactone (181), although the optical rotation data suggested 
the ee of the product may be modest. The enantiomeric excess of the synthesized (R)-γ- 
valerolactone (181) was also determined by NMR spectroscopy using two equivalents of Pirkle’s 
alcohol 189 (Figure 13). The enantiotopic methyl protons of the racemic γ-valerolactone (170), 
when introduced into the chiral environment using Pirkle’s alcohol, become diastereotopic and 
show two different signals as two doublets (J = 6.2 Hz) in 1H NMR analysis. In contrast, the 
synthetic (+)-(R)-γ valerolactone (181) shows only one signal as a doublet (J = 6.2 Hz) when 
introduced into the chiral environment using Pirkle’s alcohol 189 (Figure 13), which established 
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Figure 13. Methyl protons of a) racemic γ-valerolactone and b) (R)-γ-valerolactone with 
(R)-(-)Pirkle’s alcohol in CDCl3 
 
DCC Coupling Route for the synthesis of β-keto imide 194 
The DCC coupling method used earlier to synthesize β-keto imide 61 was applied for the 
synthesis of β-keto imide 194 as a single diastereomer, starting with enantiopure  (R)-γ 
valerolactone (181) (Scheme 42).91 The β-keto imide 194 was obtained as a single diastereomer 
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between the keto and imide carbonyls and the presence of enolic protons around 13.6 ppm 
suggests the presence of β-keto imide 194 in both keto and enolic forms.   
	  
Scheme 43. Synthesis of β-keto imide 194 as a single diastereomer 
 
The zinc-mediated tandem chain extension-aldol reaction of β-keto imide 194 with 
aldehyde 176 afforded an aldol product, presumed to be 195 and its hemiacetal 196 (Scheme 
43). The presence of open chain form 195 and two possible diastereomers of hemiacetal 196 was 
confirmed by 1H NMR spectroscopy where three methyl doublets with coupling constant of 6.1 
Hz were observed (Figure 14). The doublets indicate the presence of isomeric forms, but it is 
unclear whether the doublet are all derived from the same aldol product or whether they are from 
other aldol isomers. The 13C NMR analysis showed two signals at 111.8 and 112.3 ppm, which 
would correspond to the two hemiacetal carbons of the two possible diastereomers of 196.  
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Figure 14. Presence of three doublets in 1H NMR of TCEA product showing presence of 
open-chain and two diastereomers of hemiacetals. 
 
Sujen Lai, a previous group member, extensively studied the zinc-mediated tandem chain 
extension-aldol reaction, including reaction of β-keto imides. Lai observed that anti-aldol 
product 198 was the only isomer formed during the TCEA reaction of β-keto imide 197 with 
benzaldehyde (Scheme 44). Lai confirmed the stereochemistry of the anti-aldol product 198 
unambiguously by X-ray crystallography. Hence, previous studies by Lai, Aiken and also the 
Heathcock model31 provides good evidence that the zinc-mediated tandem chain extension-aldol 
reaction involving β-keto imides react with aldehyde via an open transition state. Based on these 
results the favored Z-enolate of β-keto imide 199 is proposed to attack aldehyde 176 from the si-
face through an open transition state 200, leading to the anti-aldol product 195, which exists in 
equilibrium with its hemiacetal 196 (Scheme 45). The syn-aldol product 202, which would result 
from the attack of Z-enolate of β-keto imide 194 on the re-face of aldehyde 176, is less likely to 
form due to an undesired steric interaction between the alkyl chain of the aldehyde and the 
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oxazolidinone ring in the transition state 201 (Scheme 45). The syn-isomer could also result 
from reaction via a closed transition state. 
 
	  
Scheme 45. TCEA reaction of β-keto imide 197 by Lai. 
 
	  
Scheme 46. Formation of anti-aldol product 195 from the transition state 200 of favored Z- 
enolate 199 
 
Tetrabutylammonium fluoride (TBAF) mediated deprotection of TCEA product 196 
followed by spirocyclization using p-toluenesulfonic acid (pTsOH) should afford the desired 
spiroketal backbone of the natural product. In the initial attempt, the TCEA product was 
deprotected using TBAF and the crude reaction mixture was treated with pTsOH and refluxed in 
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did not afford the desired spiroketals and the 1H NMR analysis showed mostly the deprotected 




Scheme 47. Attempt towards spiroketals synthesis using deprotection followed by 
spiroketalization 
 
An alternative approach for spiroketalization was desired. Careful review of the total 
syntheses of ent-CJ-12,954 141 and ent-CJ-13,014 142 reported by Brimble et al. suggested a 
different approach. The spiroacetals 134 and 135 synthesized by Brimble et al. (Figure 15) are 
advanced intermediates in the total synthesis of ent-CJ-12,954 141 and ent-CJ-13,014 142.81 The 
presence of two different protecting groups in this alternate approach would allow for selective 
deprotection. The tert-butyldiphenyl protecting group would be expected to be stable under the 
conditions used for TBDMS removal, which can make the selective formation of spiroacetals 
possible. Hence the spiroketals 206 and 207 are considered as the new targets for the formal 
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Figure 15. Spiroacetals synthesized by Brimble et al. 
	  
Figure 16. New targets for formal synthesis of CJ-12,954 and CJ-13,014  
  
The new target for formal synthesis employs aldehyde 209 in the zinc-mediated tandem 
chain extension-aldol reaction. Monoprotection of 1,4-butanediol (179) as tert-butyldiphenylsilyl 
ether 208 followed by Swern oxidation afforded the desired aldehyde 209 for TCEA reaction 
(Scheme 47).97, 98 Tandem chain extension-aldol reaction of β-keto imide 194 and aldehyde 209 
did not afford efficient formation of the desired aldol product 210. After repeated formation of a 
complex reaction mixture from the TCEA reaction with very low yield of the product, it was 
postulated that the reaction’s complexity was due to reactivity of the β-keto imide. From 
previous studies as discussed in Chapter 1, exposure of β-keto imides to zinc carbenoid for 
extended reaction times resulted in the formation of two major by-products, which were 
identified as α-methylated γ-keto imide 25 and bicyclic lactone which will be discussed in 
Chapter 3.29, 99 Hence a modified TCEA reaction was performed. Aldehyde 209 was added to 
the carbenoid prior to addition of the β-keto imide 194. This experimental modification yielded 
the desired TCEA product 210 and its hemiacetal (211) isomers (Scheme 48). The presence of 
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Scheme 48. Synthesis of aldehyde 209 
	  	  
Scheme 49.  TCEA reaction of β-keto imide 194 and TBDPSiCl protected aldehyde 209 
 The presence of two different silyl ethers, tert-butyldimethylsilyl and tert-
butyldiphenylsilyl, in the TCEA product offers the opportunity to selectively deprotect one silyl 
ether while leaving the other silyl ether intact. Brimble et al. employed this strategy to access the 
spiroketals 134 and 135 from protected dihydroxy ketone 133, where the tert-butyldimethylsilyl 
ether was deprotected using camphorsulfonic acid while the tert-butyldiphenylsilyl ether was 
unaffected (Scheme 31).81, 82 Following a similar protocol, the hemiacetal 211 was subjected to 
spirocyclization using camphorsulfonic acid (Scheme 49). The successful deprotection of the 
TBDMS ether afforded four different spiroketals, as determined by both TLC and 1H analysis. 
The NMR analysis suggested the presence of two major and two minor isomers. Spiroketals 212 
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spiroketals 214 and 215 are believed to have resulted from minor amounts of the other possible 
anti-aldol isomers (Figure 17). Syn aldol products could also be the source of the minor isomers, 
although these possible products are not illustrated. No studies were done to confirm the origin 
of the two other spiroketals. Spiroketals 212 and 213 are tentatively identified as the desired 
spiroketals by comparison of their 1H and 13C NMR spectra to the spiroketals reported by 
Brimble et al. A key difference is the absence of an acyl oxazolidinone as part of the Brimble 
intermediate. 
	  
Scheme 50. Spirocyclization of TCEA product 211 using camphorsulfonic acid 
 
	  
Figure 17. Spiroketals from the other possible anti-aldol product 
 The spiroketals 212 and 213 were purified by column chromatography. Hydrolysis of the 
imide followed by decarboxylation was expected to afford the final spiroketals 206 and 207, thus 
completing the formal synthesis (Figure 16). Brimble et al. obtained equal quantities of 
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of stereocontrol from anomeric and steric effects. Hence the Brimble team completed the 
synthesis using a 1:1 mixture of spiroacetals 134 and 135, obtaining an inseparable 1:1 mixture 
of ent-CJ-12,954 and ent-CJ-13,014 at the end of their total synthesis. Our ability to separate 
compounds 206 and 207 offers an advantage in that each isomer could be cleanly transformed 
into their respective natural products, assuming that the reaction conditions used for completing 
the synthesis of the natural product did not result in epimerization of the ketal stereocenter.  
 Lithium hydroperoxide-mediated removal of the oxazolidinone of spiroketal 212 afforded 
the carboxylic acid 216 (Scheme 50).100 Following the reported procedure developed by Evans et 
al., the spiroketal 212 was dissolved in a 3:1-THF/H2O mixture and treated with hydrogen 
peroxide followed by lithium hydroxide. Lithium hydroperoxide is formed and cleaves the 
exocyclic carbonyl of the acyl oxazolidinone to provide carboxylic acid 216 and oxazolidinone 
161 (Scheme 50).100 The reaction was quenched and buffered to pH 10 with aqueous sodium 
bicarbonate. The volatile solvent was evaporated and the aqueous residue was extracted with 
dichloromethane in an effort to remove the deacylated chiral oxazolidinone 161. The aqueous 
layer was acidified to pH 1 and extracted with ethyl acetate in an unsuccessful effort to isolate 
the carboxylic acid 216. Both the carboxylic acid 216 and chiral oxazolidinone 161 were 
recovered from the dichloromethane layer. Repeated extraction protocols were investigated in an 
effort to separate 216 and 161, however no suitable conditions were identified. While the 
compounds were found to have a similar Rf in the majority of solvent systems, thus making 
chromatographic separation challenging, flash column chromatography using gradient mobile 
phase of methyl tert-butyl ether (MTBE) and hexane eventually afforded the carboxylic acid 216 
as a pure compound free from chiral oxazolidinone 161. Following the similar protocol 
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spiroketal 213 was subjected to hydrolysis and purified by chromatography to afford the 
carboxylic acid 217 (Scheme 51). 
 
	  
Scheme 51. Lithium hydroperoxide mediated hydrolysis of carboximide of spiroketal 212 
 
	  
Scheme 52. Lithium hydroperoxide mediated hydrolysis of carboximide of spiroketal 213 
Barton decarboxylation of spiroketals 216 and 217 
Barton decarboxylation is a valuable synthetic tool to convert alkyl carboxylic acids to 
various different functionalities. In the Barton decarboxylation, a carboxylic acid is converted to 
its thiohydroxamate ester (often called a Barton ester), which undergoes homolytic cleavage, 
generally initiated by light or heat, to generate 2-pyridylthiyl radical and acyloxy radical 
(Scheme 52).101 The alkyl radical generated by radical decarboxylation of acyloxy radical can 
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functional group. Barton reductive radical decarboxylation can be achieved by treating alkyl 
radical with a hydrogen donor.  
   	  
Scheme 53. Barton decarboxylation 
 
 In order to develop experience with the Barton decarboxylation methodology, initial 
reactions were not performed on either spiroketals 216 or 217. Decarboxylation was first 
attempted on the hemiacetal 220, obtained from the hydrolysis of carboximide of hemiacetal 219 
(Scheme 54).27 The hemiacetal 219 was obtained from the TCEA reaction of β-keto imide 175 
derived from racemic γ-valerolactone (170) and aldehyde 209 (Scheme 53), therefore 219 was a 
mixture of diastereomers. Barton decarboxylation of the hemiacetal 220 gave a complex reaction 
mixture (Scheme 54). 1H and 13C NMR spectra of the crude reaction mixture and NMR analysis 
of fractions obtained from preparative thin layer chromatography showed the presence of Barton 
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Scheme 54. TCEA reaction β-Keto imide 175 and aldehyde 209  	  
	  
Scheme 55. Attempted Barton decarboxylation on carboxylic acid 220 
 
 Though the reasons for unsuccessful Barton decarboxylation of carboxylic acid 220 were 
unknown, hemiacetal 220 was likely not an ideal substrate for decarboxylation due to the 
presence of the hemiacetal. Our next attempt was focused on the carboxylic acid 216 prepared 
from spiroketal 212. Barton decarboxylation of carboxylic acid 216 was expected to afford the 
desired spiroketal 206, which would complete the formal synthesis. Following the procedure 
reported by Thomas et al., carboxylic acid was treated with oxalyl chloride to give the 
corresponding acyl chloride (Scheme 55).102 The acyl chloride was then dissolved in anhydrous 
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refluxing suspension of 2-mercaptopyridine N-oxide in anhydrous benzene containing DMAP 
and tert-butyl thiol (Scheme 55).102 After a two-hour reflux with irradiation, the reaction mixture 
was worked up. The 1H and 13C NMR spectra of the crude reaction mixture did not show any 
traces of the desired product.  
Tsanaktsidis et al. reported the use of chloroform as the hydrogen atom source in a 
Barton decarboxylation reaction, thus reducing the cost, toxicity and/or smell of traditional 
Barton decarboxylation reaction, which uses tributyltin hydride or tert-butyl thiol as the 
hydrogen source.103 Barton decarboxylation with chloroform as the hydrogen source was 
attempted on carboxylic acids 222 and 223, which were obtained from the hydrolysis of 
spiroketals 214 and 215 (Scheme 56) using the procedure reported by Tsanaktsidis et al (Scheme 
57).103 The stereochemistries at C-7 and C-8 of spiroketals 214 and 215 are not known..  
	  
Scheme 56. Attempted Barton decarboxylation on spiroketal 216 
  
Since the earlier attempts of Barton decarboxylation were unsuccessful, it was important 
to confirm formation of the acid chloride from the carboxylic acid. The mixture of carboxylic 
acids 222 and 223 were treated with oxalyl chloride in anhydrous dichloromethane (Scheme 57). 
The formation of acyl chloride from carboxylic acid was monitored by 1H NMR, 13C NMR and 
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upfield of the carbonyl in the carboxylic acids 222 and 223, which confirmed formation of the 
acid chloride. The acid chloride was then added drop-wise to the refluxing suspension of 1-
hydroxypyridine-2(1H)-thione sodium salt and DMAP in chloroform with concomitant 
irradiation from a halogen lamp. 
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The crude reaction mixture obtained after work-up did not show any evidence of 
decarboxylated product from 1H and 13C NMR analysis. Barton decarboxylation using 
chloroform as the hydrogen atom source was next attempted on the carboxylic acid 216 with 
minor modifications (Scheme 58).  
 Commercial chloroform includes ethanol as the stabilizer to enhance solvent shelf life. 
However, addition of ethanol will increase the polarity of the solvent and can impact certain 
chemical reactions. In order to remove the traces of ethanol, chloroform was washed with water, 
dried over potassium carbonate and distilled over P2O5. N-Mercaptopyridine oxide sodium salt 
was dried under high vacuum prior to use. The carboxylic acid 216 was treated with oxalyl 
chloride in anhydrous dichloromethane for 30 min. The resulting acid chloride was dried under 
high vacuum for 10 min to remove any excess oxalyl chloride. The crude acid chloride was 
dissolved in distilled chloroform and added drop-wise over 10 min to a refluxing white 
suspension of 1-hydroxypyridine-2(1H)-thione sodium salt and DMAP in distilled chloroform 
with concomitant irradiation from a halogen lamp (Scheme 58). The reaction mixture turned 
from a white suspension to a light yellow colored mixture upon addition of the acid chloride.  
The crude reaction mixture showed the presence of two spiroketals. The crude reaction mixture 
was separated by preparative thin layer chromatography to afford spiroketal 206 and its epimer at 
the spiroketal carbon 207 in 40% yield. Barton decarboxylation of carboxylic acid 217 gave the 
spiroketals 206 and 207 (Scheme 59).  
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Scheme 59. Barton decarboxylation on carboxylic acid 216 using chloroform as the 
hydrogen atom source. 
 
 
Scheme 60. Barton decarboxylation on carboxylic acid 217 using chloroform as the 
hydrogen atom source. 
 
Brimble et al. synthesized the spiroketals 134 and 135, which are the enantiomers of 
spiroketals 206 and 207, as key intermediates in their total synthesis of ent-CJ-12,954 (141) and 
ent-CJ-13,014 (142). However, they were unable to separate the 1:1 mixture of spiroketals 134 
and 135. In our attempt towards the formal synthesis of CJ-12,954 (126a) and CJ-13,014 (126b), 
decarboxylation of the carboxylic acid 216 afforded the two spiroketals, 206 and its epimer at the 
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Characterization of spiroketals 206 and 207  
 In a similar fashion to the hydrolysis of spiroketal 212 to afford the carboxylic acid 216, 
spiroketal 213 was hydrolyzed to the carboxylic acid 217. The carboxylic acids 216 and 217 
were subjected to Barton decarboxylation using chloroform as the hydrogen atom source to 
afford the desired spiroketals 206 and 207. While application of the model for predicting 
stereochemistry of the TCEA reaction and the known stereochemistry of the starting material 
suggested that 206 and 207 were enantiomers to Brimble’s 134 and 135, careful comparison of 
NMR spectra was necessary to confirm the prediction.  
The 1H and 13C NMR of the synthesized spiroketals 206 and 207 are compared to the 
spiroketals 134 and 135 reported by Brimble et al (Table 6). Since Brimble et al. were unable to 
separate the two spiroketals 134 and 135, some of the 1H and 13C resonances were not assigned 
to a specific spiroketal. However, the characteristic resonances of quaternary spiroketal carbons 
at δ 114.3 and 114.7 were assigned to spiroketals 134 and 135 respectively (Table 7). These 
assignments were made by Brimble et al., on comparison of their spectral data with the Dekker et 
al. data for the  natural products. Based on this information, we have characteristic resonances at 
δ 114.4 and 114.6 corresponding to the two quaternary carbon resonances in the 13C NMR 
spectrum to spiroketals 206 and 207, respectively.  
Brimble et al. also matched the spectral data of 1H doublets assigned to the methyl group 
with the natural product spectral data. However this comparison was made on the final products 
(ent-CJ-12,954 and ent-CJ-13,014 and natural products CJ-12,954 and CJ-13,014) and not on the 
spiroketals 134 and 135. The 1:1 mixture of spiroketals 134 and 135 showed doublets at δ 1.23 
and 1.29 ppm; however, resonances are not matched to a specific spiroketal. Based on this 
spectral data we characterized the doublets at δ 1.20 and 1.26 ppm (J = 6.2 Hz), corresponding to 
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the methyl group in spiroketals 206 and 207 respectively. Hence, the spectral data of the key 
quaternary carbons and doublets due to the methyl groups are in general, good agreement with 
the data reported by Brimble et al. (Table 6 and Figure 18). The stereocenter C2 was derived 
from (R)-γ-valerolactone (181) and the stereocenter incorporated in Brimble’s study was S; the 
excellent match of these resonances is consistent with the enantiomeric relationship of the 
spiroketals. Hence the synthesized spiroketals 206 and 207 are enantiomers of the spiroketals 
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              Table 6. 1H NMR assignment of spiroketals 206 and 207 compared to their 



























Brimble et al. 
Spiroketals 134 and 135
(S, S, S) and (S, R, S)
H atom Spiroketal 206 (R, R, R)
Spiroketal 207
    (R, S, R)
1.07 (s, 9H)
1.23 (d, J = 6.2 Hz, 1.5H)
1.29 (d, J = 6.2 Hz, 1.5H)
1.43-1.78 (m, 6H)
1.91-2.17 (m, 6H)
3.70 (t, J = 6.2 Hz, 2H)
4.06-4.13 (m, 1H)
4.20 (qd, J = 6.3, 6.3 Hz, 1H)
7.37-7.45 (m, 6H)
7.69 (dd, J = 7.3, 1.4 Hz)
1.04 (s, 9H)
1.2 (d, J = 6.2 Hz, 3H)
1.53-1.80 (m, 6H)
1.88-2.16 (m, 6H)
3.67 (t, J = 6.3 Hz, 2H)
4.0-3.97 (m, 1H)
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Figure 18. 1H NMR spectra of spiroketals 206 (R, R, R) and 207 (R, S, R) 
 
There are 21 distinct carbons in each of the spiroketals 206 and 207 including the two 
diastereotopic phenyl groups, however 17 carbon resonances were observed by the 13C NMR 
(Figure 19 and Figure 20). A DEPT 135 spectrum was also obtained for the spiroketal 206 
(Figure 21). DEPT was used as a valuable tool to confirm the transformation of spiroketal 212 to 
carboxylic acid 216 and ultimately to decarboxylated spiroketal 206. Two methyl carbons, seven 
methylene, five methine and two quaternary carbons in spiroketal 206 were confirmed by the 
DEPT spectrum. The disappearance of the two quaternary carbons from the 13C NMR spectrum 
(Figure 19) in the DEPT spectrum (Figure 21) also confirms the resonances for the quaternary 
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The resonances of the spiroketals 206 and 207 are in good agreement with the spiroketals 
134 and 135. Since the methyl (C1), quaternary (C5) and the two methine (C2 and C7) could be 
unambiguously identified by DEPT analysis, the resonances were compared. The methine carbon 
C7 of spiroketals 134 and 135 was assigned by Brimble to the resonances at δ 79.7 and 77.9, 
respectively. Similar to these assignments, the methine carbon C7 of spiroketals 206 and 207 
also showed resonances at δ 79.7 and 77.9 ppm, respectively. The methine carbon C2 of 
spiroketals 134 and 135 was assigned for the resonances at δ 75.8 and 74.0 ppm, respectively, by 
Brimble et al (Table 7, Figure 19 and 20). In contrast to their assignments, the methine carbon 
C2 of spiroketals 206 and 207 showed the resonances at δ 73.7 and 75.8 ppm, respectively.  
Brimble et al. assigned the resonance for methyl carbon in 13C NMR at δ 23 ppm for spiroketal 
134 (S, S, S) and at δ 21.2 ppm for spiroketal 135 (S, R, S). In contrast to their assignments the 
targeted spiroketals 206 (R, R, R) and 93 (R, S, R) showed resonances for the methyl carbon in 
13C NMR at δ 21.2 ppm and 23 ppm respectively (Table 7, Figure 19 and 20). However these 
assignments were made by Brimble et al., on a 1:1 mixture of 134 and 135. Hence they may not 
have been able to appropriately assign specific resonances to a particular spiroketal. It might be 
possible that the assignments made by Brimble et al. for the methyl carbon and the methine C2 
carbon was incorrect. Requests were made for reported data and samples from Brimble, 
however, she reported that the data was no longer available. All the other 1H and 13C NMR 
resonances are in excellent agreement with the reported values by Brimble et al.  
In summary, successful synthesis of spiroketals 206 and 207 completed the formal 
synthesis of the natural products CJ-12,954 and CJ-13,014. The spectral data of the spiroketals 
206 and 207 are in good agreement with the spiroketals 134 and 135 (enantiomers of 206 and 
207) synthesized by Brimble et al. The stereochemistry at C7 carbon was controlled by zinc-
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mediated tandem chain extension aldol reaction. Extensive studies by Aiken and Lai on zinc-
mediated chain extension-aldol reaction of β-keto imides suggest that an anti-aldol isomer is 
formed, possibly through an open transition state. Hence, we believe that the stereochemistry at 
C7 is R, consistent with an anti-aldol isomer and facial selectivity imparted by the oxazolidinone. 
However, no X-ray crystallographic data was obtained to confirm the stereochemistry of the 
aldol reaction. Previous studies in Zercher group and excellent agreement of our spectral data 
with Brimble et al. can be used to support that the synthesized spiroketals 206 and 207 and 
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Table 7. 13C NMR assignment of spiroketals 206 and 207 compared to their   enantiomers 

























13C NMR Brimble et al. 
spiroketals 134 (S, S, S) and 135
 (S, R, S)
Carbon atom Spiroketal 206 (R, R, R)
Spiroketal 207
    (R, S, R)
19.2













74.0 (135) and 75.8 (134)
77.9
79.7 (134)
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Figure 21. DEPT spectra a) DEPT-135 (CH3, CH and CH2 carbons) b) DEPT-90 (CH 
carbons) c) DEPT-45 (all protonated carbons) of spiroketal 206 
  
In summary, zinc-mediated tandem chain extension-aldol reaction methodology was 
successfully used for the formal synthesis of the spiroketals 206 and 207. Spiroketals 206 and 
207 are the enantiomers of spiroketals 134 and 135, which are the key intermediates in the total 
synthesis of ent-CJ-12,954 (141) and ent-CJ-13,014 (142). The spiroketals 206 and 207 are 
characterized by 1H, 13C and DEPT spectra. Since spiroketals 206 and 207 have the desired 
stereochemistry as the natural products CJ-12,954 (126a) and CJ-13,014 (126b), 206 and 207 
can also be converted to the natural products (126a) and (126b) using the synthetic route 
followed by Brimble et al. Other spiroketal based natural products can also be targeted using this 
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CHAPTER III 
 
SYNTHESIS AND INVESTIGATION OF DIASTEREOSELECTIVITY OF 
HYDROXY-CYCLOPROPYL PEPTIDE ISOSTERES 
 
 
Peptide isosteres were developed to increase the metabolic stability of oligopeptides and 
in some cases to reduce their conformational flexibility. Peptidomimetics are mimics of naturally 
occurring peptides that contain synthetically-derived peptide isosteres. In 1919 Langumir first 
described the term ‘isostere’, which refers to two molecules containing the same number of 
atoms and valence electrons.104 Peptide isosteres are attractive tools for the analysis of enzyme 
and substrate interactions.105 Proteases are a class of enzymes promoting the hydrolysis of 
peptide bonds.  
Peptide isosteres have proven to be effective in the inhibition of a variety of proteases 
including HIV aspartyl protease.106, 107 HIV aspartyl proteases plays a vital role in the replication 
of HIV virus by site-specific cleavage of a polypeptide chain into peptide fragments (Scheme 
60). Despite successful inhibition of the aspartyl proteases through peptide isosteres, the highly 
mutative nature of the HIV virus mandates continued development of novel peptide isosteres 
with increased efficiency to expand the therapeutic opportunities.108The protease targets often 
require the development of a wide array of peptide mimics. 
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A variety of functional groups like (E)-alkenes,109 silanols110 and dihydroxy ethylene111 
have been used to mimic the peptide bond. Various factors such as functionality, bond angles, 
hybridization of the amide mimic, stereochemistry and hydrogen bonding capabilities influence 
the efficiency of the peptide isosteres. Efforts have been mainly directed towards replacing the 
amide bond with functionalities resistant to hydrolysis, while maintaining recognition for the 
active site.  
The replacement of the amide nitrogen of a peptide bond with a methylene unit results in 
formation of a ketomethylene peptide isosteres 227.112, 113 An advantage of the ketomethylene 
isostere is that the ketone adopts the tetrahedral geometry upon nucleophilic attack, yet this 
isostere is hydrolytically stable unlike an amide bond. While amide resonance results in 
restricted rotation and a strong conformational bias in an amide bond, ketomethylene peptide 
isosteres possess lower barrier rotation around the isosteric carbon-carbon bond, thereby lacking 
the rigidity needed for optimized binding to an active site. Another common peptide isostere 
extensively explored in protease inhibition is the hydroxyethylene isostere 228.113-115 
Hydroxyethylene isosteres have the advantages of hydrolytic stability and also hydrogen-
bonding capability in the enzyme’s active site; however, carbon-carbon bond rotation is facile 
and non-binding conformations are extensively populated.  
	  
      Figure 22. Ketomethylene and hydroxyethylene peptide isosteres 
Zinc-mediated chain extension reaction for the preparation of peptide isosteres  
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these isosteres can be challenging. Lengthy synthetic routes and limited stereocontrol make the 
synthesis of many peptide isosteres difficult. The Zercher research group has developed an 
efficient approach to the synthesis of ketomethylene isosteres employing a zinc carbenoid-
mediated chain extension reaction (Table 8).116 Various amino acids were converted to the 
corresponding ketomethylene isosteres. The C-terminus of the N-protected amino acid was 
converted to a β-keto ester using a mixed Claisen protocol. The derivatized amino acid was 
subjected to zinc carbenoid-mediated chain extension conditions to afford the corresponding γ-
keto ester. This reaction showed high tolerance towards variety of amino acids. A single 
enantiomer of selected amino acids was subjected to this sequence of reactions. The substrates 
underwent little racemization during the formation of the β-keto ester and no racemization during 
chain extension conditions. 
	  
Table 8. Two-step synthesis of amino acid derived γ-keto methyl esters 	  
The tripeptide mimic 235 was synthesized using the chain extension strategy to further 
demonstrate the scope of the reaction. No epimerization of the amino acid stereocenters in the 

















b) Mg(O2CCH2CO2CH3)2 Et2Zn, CH2I2
229a-h 230a-h 231a-h
Entry P R 230 (%Yield) 231 (%Yield)
229a Boc H 91 25
229b Boc Me 70 48
229c Cbz H 65 60
229d Cbz Me 66 60
229e Bz H 65 58
229f Bz Me 47 58
229g Fmoc H 65 55
229h Fmoc Me 76 57
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approach for the formation of ketomethylene isosteres using zinc carbenoid-mediated chain 
extension reactions was also developed.117 Lin, a previous Zercher group member, reported the 
synthesis of a single diastereomer 235 using a zinc-mediated homologation reaction. A 
stereoselective synthesis of a functionalized dipeptide isostere employing zinc-carbenoid 
mediated chain extension reaction has been reported by Zercher group.118  
	  
Scheme 62. Synthesis of tripeptide 235 
Cyclopropane peptide isosteres 
 Although ketomethylene and hydroxyethylene peptide isosteres were found to have good 
affinity to bind HIV-1 protease inhibitors, decreased conformational rigidity by restriction of free 
rotation around carbon-carbon bond was suggested as a route to enhance binding. Research into 
the development of more rigid isosteric replacement to the amide bond led to the development of 
cyclopropyl peptide isosteres. Wipf and Xiao first prepared the cyclopropyl isosteres from 
alkenyl dipeptide isosteres.119 Martin and co-workers synthesized a C2-symmetrical α-tri-
substituted cyclopropyl peptide isostere 236 for inhibition of aspartic protease of HIV-1 (Figure 
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X-ray analysis. The cyclopropanes in these peptide isosteres were designed to maintain 
conformational integrity of the chain and be hydrolytically stable.  
	  
Figure 23. Peptidomimetic 236 
Novel cyclopropanol peptide isosteres 
A novel cyclopropanol peptide isostere 237 has been designed by the Zercher group 
(Figure 24).29 This novel peptide isostere containing the cyclopropanol moiety as a replacement 
for the amide linkage is envisioned to be non-hydrolyzable, conformationally-biased and capable 
of hydrogen-bonding. The individual carbons of this cyclopropanol peptide isostere are also 
capable of being functionalized stereoselectively, which offers the potential to design more 
efficient inhibitors for mutation-prone proteases. The cyclopropanol moiety is provided by 
adaptation of the zinc-mediated reaction sequence that results in the formation of bicyclic 
lactones, which upon opening releases a cyclopropanol. The use of amino acids as starting 
materials provides the environment for inclusion of the cyclopropanol as part of the proposed 
















primary binding to active site
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Figure 24. Novel cyclopropanol peptide isostere 
Homologation-cyclopropanation reaction for the preparation of peptide isosteres 
 Both Lin and Pu, previous Zercher group members, observed the formation of a 
cyclopropanol 238 as a minor byproduct during the tandem homologation-aldol and tandem 
homologation-homoenolate formation reaction of β-keto imides, respectively (Figure 25).23, 28 
The unique structure of this byproduct was envisioned as a potential synthetic building block. 
Taschner observed formation of a similar product and explored this transformation in more 
detail, which resulted in the identification of mechanistic insights and the preparation of an array 
of cyclopropanol products.29 
	  
Figure 25. Unexpected cyclopropanol by-product 	  
A homologation-aldol reaction of β-keto imide 238 was performed by Taschner during 
his efforts to synthesize the plakortether backbone. A cyclopropanol byproduct 241, with 
undetermined stereochemistry, was isolated in small quantities (Scheme 62). The cyclopropanol 
byproduct 241 was proposed to result from the intramolecular cyclization of the homoenolate 
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presence of the cyclopropanol byproduct was confirmed by the reduction of 241 using 
triethylsilane and boron trifluoride, which afforded two cyclopropylfuranyl diastereomers 246 
and 247 (Scheme 64). The stereochemical assignment of the major isomer 246 was determined 
by an NOE experiment.29 
	  
Scheme 63. Cyclopropanol byproduct formed during homologation-aldol reaction 	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Scheme 65. Silane reduction of cyclopropanol 241 
Various attempts by Taschner to increase the yield of cyclopropanol 241 resulted in the 
formation of minor quantities of 241 or no cyclopropanol product. Hilgenkamp reported that the 
use of TMS-Cl in the zinc-mediated chain extension enhanced formation of the homoenolate 
intermediate. The TMS-Cl was proposed to produce a more reactive zinc-bound enolate, which 
would react with excess zinc carbenoid to form the homoenolate.120 Hence, Taschner attempted 
the homologation-cyclopropanation of β-keto ester 248 in the presence of stoichiometric TMS-
Cl. The TMS-protected cyclopropanol 250 was generated in the reaction (Scheme 65). The 
relative stereochemistry of the TMS cyclopropanol 250 was not reported. 
Cyclopropanol formation involving the keto moiety was opposite the result observed by 
Lin and Pu, for whom the cyclopropanol had been formed at the imide carbonyl. The unusual 
product reported by Taschner was proposed to result from rearrangement of silyl ether 249 
during the TMS-promoted homologation-alkylation reaction (Scheme 65). Lewis acid-mediated 
cyclization of cyclopropylsilyl ether 250 produced bicyclic lactone 251. Benzyl amine opening 
of the bicyclic lactone 251 to cyclopropanol 252, which was the first compound to incorporate 
the cyclopropyl moiety as a potential isosteric replacement for the amide bond (Scheme 65). 
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Scheme 66. First incorporated cyclopropanol isostere 
Tandem homologation-cyclopropanation-rearrangement-lactonization (HCRL) 
 Various studies were performed by Taschner in an effort to optimize the conditions for 
the preparation of the bicyclic lactone 251. The ease of formation of zinc cyclopropanoxide in β-
keto imides due to the electrophilicity of the imide carbonyl led to the use of β-keto imides in the 
place of β-keto esters for the preparation of bicyclic lactones. The lactonization reaction in the 
presence of TMS-Cl gave low yields, possibly due to the quenching of the carbenoid with any 
trace amounts of HCl present in the TMSCl. Taschner’s study of the oxazolidinone starting 
materials resulted in complicated reaction mixtures and discovered that bis-carbenoid was better 
for lactone formation. Taschner identified that use of bis-carbenoid in place of the Furukawa 
carbenoid resulted in higher yield, presumably due to less by-product formation. Hence the 
optimized conditions for the homologation-lactonization reaction utilized five equivalents of the 
bis(iodomethyl)zinc carbenoid, and the yield of the bicyclic lactone was increased to 50% 
(Scheme 66).29 The direct conversion of β-keto imide to bicyclic lactone was proposed to 
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Scheme 67. Homologation-Lactonization of β-keto imide 
 
The homologation-cyclopropanation reaction of β-diketones has been extensively studied 
in the Zercher research group and these studies were discussed in Chapter 1.32, 33 Equilibration 
of isomeric cyclopropoxide plays a role in product formation in the homologation-
cyclopropanation reaction of β-diketones, and studies on these substrates provided mechanistic 
insights into the mechanism of homologation-lactonization reaction.32 The reaction mechanism 
that leads to bicyclic lactone formation is believed to be similar to the chain extension- 
cyclopropanation of β-diketones, but lactone formation requires both cyclopropoxide 
rearrangement and intramolecular acylation using the imide carbonyl (Scheme 67). Hence the 
cascade reaction that results in conversion of β-ketoimide to lactone has been termed the 
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Scheme 68. Proposed mechanism of the HCRL reaction 
 
The proposed cyclopropoxide rearrangement in the HCRL reaction was confirmed by 
trapping the initially formed cyclopropane intermediate with TMSCl. Taschner isolated the 
trapped silylcyclopropyl ether 256 as a single diastereomer and the stereochemistry was 
confirmed by X-ray crystal structure analysis (Scheme 68).29 The silylcyclopropyl ether 256 was 
derived from enantiomerically pure β-keto imide 255 and the stereochemistry of the 
cyclopropane in 256 was controlled by the chiral auxiliary, in a fashion consistent with the 
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Scheme 69. Rearrangement-cyclization of TMS ether to bicyclic lactone 
 
 The TMS-protected cyclopropanol 256 was treated with tetramethylammonium fluoride  
(TMAF) to afford the bicyclic lactones 257 and 258. To determine the enantiomeric ratio  of the 
bicyclic lactone resulting from diastereomer 256, the lactones were opened with (R)-methyl 
benzyl amine. The diastereomeric ratio of the amide products was observed as 2.3:1. This result 
suggests that even though initial cyclopropanation was controlled by the chiral auxiliary, the 
stereochemistry of the bicyclic lactone was compromised by lack of stereocontrol in the 
cyclopropanation rearrangement (Scheme 69). 
	  
Scheme 70. TMAF induced desilylation-rearrangement-lactonization 
From the poor diastereomeric ratio of the cyclopropyl alcohol-containing amide, it was 
concluded that the chirality within the oxazolidone moiety provided insufficient stereocontrol. 
Hence Taschner used amino acid-derived β-keto imides for the HCRL reaction to study the role 
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incorporated an achiral oxazolidone into the β-keto imides.  Taschner attempted different 
methods to synthesize the β-keto imide starting materials; however, the DCC-coupling route 
reported by Raillard and co-workers provided the best results.91  
The first β-keto imide 262 synthesized using the DCC coupling method was derived from 
Boc-protected proline and an achiral oxazolidone. However, the HCRL reaction of 262 did not 
yield bicyclic lactone 263, possibly due to the Boc-decomposition mediated by the Lewis acidic 
Zn(II) species present. The protecting group was changed from t-butyl carbamate (Boc) to benzyl 
carbamate (Cbz) 264, and a mixture of bicyclic lactones 265 and 266 were generated (Scheme 
71). The other β-keto imides studied were derived from valine 267 and phenylalanine 268, which 
afforded the corresponding lactones from the HCRL reaction (Scheme 72). 
	  
Scheme 71. HCRL of β-keto imide 263 	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Scheme 73. HCRL of Valine and Phenylalanine derived β-keto imides 
Taschner efforts for the stereochemical determination of major bicyclic lactone 
 In an effort to probe the diastereoselectivity of the reaction, Taschner attempted different 
strategies to identify the relative stereochemistry of the major diastereomer of the bicyclic 
lactone derived from the HCRL reaction of amino acid-derived β-keto imides. The first lactone 
to be studied was the Cbz-protected proline- derived lactone 273. The major diastereomer of 
lactone 274 was subjected to a hydrogenolysis reaction to remove the benzyl carboxy protecting 
group. The deprotected lactone 274 was afforded as an oily solid (Scheme 73). Attempts to grow 
an X-ray quality crystal of lactone 274 were unsuccessful.  
	  
Scheme 74. Hydrogenolysis of bicyclic lactone 271 
The Cbz-protected proline-derived lactone 273 was also subjected to benzyl amine 
opening followed by hydrogenolysis to afford the cyclopropanol 274 (Scheme 74). Acylation 
and intramolecular cyclization of 276 using triphosgene was expected to afford the rigid tricyclic 
277, which would allow for NOE studies. However, cyclization using triphosgene was 




















R = CH(CH3)2 (267)
R = CH2C6H5  (268)
R = CH(CH3)2 (269) and (270)
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Scheme 75. Attempt at rigid structure 277 for NOE studies  
Due to the failure of the above attempted methods and the challenges imposed by 
carbamate rotamers, Taschner studied tosyl-protected proline-derived lactones 279 and 280. The 
products were synthesized and subjected to benzyl amine opening (Scheme 75). Taschner 
attempted to grow an X-ray quality crystal of the minor diastereomer yielded from benzyl amine 
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Scheme 76. Formation of bicyclic lactones followed by ring opening 
Current work 
 Taschner’s efforts to probe the stereochemistry of the major diastereomer of the bicyclic 
lactone resulting from the HCRL reaction were unsuccessful. However, the elucidation of the 
relative stereochemistry was believed to be crucial to potential application of the method. Hence 
the current work continued our efforts to probe the diastereoselectivity of the HCRL reaction and 
to confirm the stereochemistry of the major bicyclic lactone. Proline-derived substrates were 
employed for the current investigation. The study reported below focused on exploring the roles 
of the amino acid stereocenter, chiral auxiliary and the proline’s protecting group in controlling 
the diastereoselectivity of the HCRL reaction.  
Peter Moran, a previous graduate student in the Zercher group, in an attempt to 
understand the stereoselectivity of the homologation-cyclopropanation reaction of β-dketones, 
converted phenyl carbamate-protected proline cyclopropanol 283 to tricyclic species 284 by 
treatment with potassium tert-butoxide.33 The rigidity of the tricyclic species 284, facilitated 
































	   96	  
this strategy to study the stereochemistry of the major bicyclic lactone resulting from the HCRL 
reaction was proposed. 
	  
Scheme 77. Potassium tert-butoxide mediated cyclization of 60 
Synthesis of β-keto imide of phenyl carbamate protected proline 
Preparation of β-keto imide 289 started with phenyl-carbamate protected proline 
(Scheme 77). While there are other methods available for the preparation of β-keto imides,45, 121 
the mild DCC coupling method reported by Raillard and co-workers gave the best results.91 The 
route was initiated by reacting Meldrum’s acid with 286 in the presence of DCC and DMAP. A 
conventional aqueous work-up of the Meldrum’s acid adduct 287 results in decomposition of the 
product; however, the DMAP salt of the Meldrum’s acid adduct 287 has high stability. The 
DMAP salt was treated with DOWEX 50W-X2, an acidic polymeric residue, to generate the free 
Meldrum’s acid adduct, which was refluxed in toluene with the desired oxazolidinone to afford 
the corresponding β-keto imide. Following the above procedure β-keto imide 289 was 
synthesized in moderate yield. (Scheme 78).  
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Scheme 79. DCC coupling route towards the synthesis of β-keto imide 289  
 
The β-keto imide 289 was subjected to the HCRL reaction using five equivalents of the 
bis(iodomethyl)zinc to afford the bicyclic lactones 290 (S, S isomer) and 291 (S, R isomer) 
(Scheme 79) in a diastereomeric ratio of 2.6:1 as determined by 1H NMR, analysis of the crude 
reaction mixture. Mestrenova line fitting programme was used to establish the dr. The two 
diastereomers 290 and 291 co-eluted on flash column chromatography. Benzyl amine opening of 
the mixture of 290 and 291 resulted in the two cyclopropanols 292 and 293, which were 
separated by preparative thin layer chromatography (Scheme 80). The major diastereomer of the 
benzyl amine opening was subjected to a pentane diffusion chamber and a single crystal was 
grown and analyzed by X-ray diffraction (Figure 26). The product was dissolved in ethyl acetate 
and stored in a diffusion chamber filled with n-pentane to grow an X-ray quality crystal. The 
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(S, S isomer). Benzyl amine opening of the bicyclic lactones 290 and 291is a high yielding 
reaction; therefore, the major cyclopropanol 292 is assumed to be derived from the major 
bicyclic lactone 290. 
	  
Scheme 80. HCRL reaction of β-keto imide 289 	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Figure 26. X-ray crystal structure depicting the absolute stereochemistry of cyclopropane of 
cyclopropanol 292  
Chelation Model vs Felkin-Anh Model 
	  
Scheme 82. Rearrangement of zinc cyclopropanoxide to bicyclic lactones 
  
The crystal structure of the major bicyclic lactone 290 confirmed the absolute 
stereochemistry of the major bicyclic lactone of the HCRL reaction. Lactones are believed to 
result from the initial rearrangement of cyclopropanoxide 294 to the cyclopropanoxide 295 
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cyclopropanoxides (294) are expected to be formed in very similar amounts due to the achiral 
oxazolidinone. However, the stereochemistry of the cyclopropanoxide rearrangement product 
(294) determines the stereochemistry of the bicyclic lactones 290 and 291, which are formed in 
different amounts. Hence, the stereochemistry of the cyclopropanol of the bicyclic lactone is 
determined in the rearrangement step. The stereochemistry of the major bicyclic lactone (s,s)-
290, can be rationalized by a chelation model (Figure 27), in which chelation of the carbamate 
and the ketone serves to influence facial selectivity of the ketone in the rearrangement. The zinc 
cyclopropanoxide attacks the carbonyl from the least hindered face. As suggested in Figure 27, 
both of the cyclopropanols A or B rearrange to the major bicyclic lactone 290. The Felkin-Anh 
model, assigns the protected nitrogen as the large group, predicts the formation of the other 
diastereomer 291 as the major bicyclic lactone (Figure 28). 122 
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Figure 28. Felkin-Anh model would predict potential formation of the minor diastereomer 
NOE studies to determine the stereochemistry of major bicyclic lactone 
The major diastereomer 292 was subjected to cyclization to form the tricyclic compound 
297 using potassium tert-butoxide (Scheme 82). The stereochemistry of the tricyclic compound 
297 was then analyzed by NOE studies. All the protons of the tricyclic compound 297 are 
identified and characterized by gCOSY and gHSQC. Using the NOE experiment, the proline 
methane (1, Figure 29) was irradiated and the cyclopropane methine proton (2, Figure 29) was 
observed and vice-versa (Figure 29 and 30). The distance between protons 1 and 2 (Figure 29) 
is 2.596 Å (obtained from optimized structure on Spartan using Semi-empirical PM3 level of 
theory), which gives good opportunity for NOE observance (NOE observed for distances less 
than 3.5 Å). Both the NOE study and the crystal structure confirm that the major diastereomer of 
benzyl amine opening is 292. The stereochemistry of the major diastereomer of the benzyl amine 
opening can be attributed to the major bicyclic lactone resulting from the HCRL reaction. The 
major diastereomer of the HCRL reaction is bicyclic lactone 290 (S, S isomer) (Scheme 79).  
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Figure 29. NOE of the tricyclic compound 297  
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Figure 30. NOE of the tricyclic compound 297 
(methine on cyclopropane 2 was irradiated and observed proline methine proton 1) 	  
The bicyclic lactones 290 and 291 were obtained in a diastereomeric ratio of 2.6:1 from 
the β-keto imide 289 derived from the achiral oxazolidinone. A study to understand the influence 
of a chiral oxazolidinone on the diastereomeric ratio of the bicyclic lactones formed in the HCRL 
reaction was undertaken. Hence, β-keto imide 298 was synthesized by reacting the chiral 
oxazolidinone derived from L-phenylalanine with the Meldrum’s acid adduct (Scheme 83). 
However, the HCRL reaction of the β-keto imide 298 resulted in a complex reaction mixture and 
the 1H NMR of the crude reaction mixture did not show resonances of the bicyclic lactones 
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Scheme 84. Synthesis of β-keto imide 298 
	  
Scheme 85. HCRL reaction of β-keto imide 298 
Synthesis of bicyclic lactone from TMS cyclopropanol 
 An alternative strategy was employed to trap the initial cyclopropanol, which would be 
further manipulated to encourage rearrangement to the bicyclic lactones (Scheme 85). Based on 
a report of Taschner, we believed that the cyclopropanol resulting from the initial homologation-
cyclopropanation reaction could be trapped with TMSCl to afford the TMS ether (Scheme 9). 
Treatment with tetra-n-butylammonium fluoride (TBAF) would release the cyclopropanoxide 
and facilitate the rearrangement to afford the bicyclic lactones. Alternatively, as reported by 
Moran, the TMS ether could be deprotected with TBAF in the presence of acetic acid to afford 
the corresponding cyclopropanol, which upon exposure to carbenoid could afford the bicyclic 
lactones via rearrangement and acylation (Scheme 85). The ability to trap the initial 
cyclopropanol as a TMS ether and then facilitate rearrangement to afford the bicyclic lactones 














































No lactone formation observed
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Scheme 86. Synthesis of bicyclic lactones from the rearrangement of TMS ether 
  
Application of homologation-cyclopropanation conditions to 298 in the presence of 
TMSCl afforded the TMS ether as a mixture of diastereomers in a ratio of 5:1 (Scheme 86). The 
stereochemistry of the major diastereomer was controlled by the chiral auxiliary and explained 
later in the chapter. The two diastereomers could not separated by chromatograpy. Hence the 
mixture of the two diastereomers, obtained from the purification of crude reaction mixture by 
preparative thin layer chromatography, was analyzed by NMR variable temperature (VT) 
experiment to differentiate the two diastereomers from their rotameric forms due to the 
carbamate protecting group (Figure 31). 
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Figure 31. 1H NMR of TMS cyclopropanol 299 at a) 70 oC b) 25 oC 
VT Experiment of TMS cyclopropanol 299 
 A variable temperature (VT) experiment was performed on the TMS-protected 
cyclopropanol 299 at 25 oC and 70 oC to distinguish the two diastereomers from their rotameric 
forms. In the 1H NMR at 25 oC (Figure 31b), the protons of the trimethylsilyl group on the 
major diastereomer and its rotamer showed singlets at 0.27 and 0.22 ppm. Both the singlets 
coalesced as a broad singlet at 0.25 ppm at high temperature (Figure 31a). Similarly the minor 
diastereomer and its rotamer showed singlets at 0.18 and 0.16 ppm (Figure 31b). At 70 oC, both 
the singlets coalesced into a broad singlet at 0.17 ppm (Figure 31a). VT experiment provided 
good support to distinguish the major and minor diastereomers of the TMS cyclopropanol 299. 
a)#70#oC#
b)#25#oC#
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On the basis of 1H NMR analysis, the diastereomeric ratio was determined to be 5:1.  
 The TMS cyclopropanol 299 was then subjected to TBAF in anhydrous conditions to 
facilitate the rearrangement to bicyclic lactones. If the stereochemistry of the cyclopropanol 299 
exerts an influence on the facial selectivity in the addition to the ketone, the diastereomeric ratio 
of the bicyclic lactones was expected to be 5:1. In contrast to the expected results, TBAF-
mediated rearrangement of TMS cyclopropanol afforded only the bicyclic lactone 290 (S, S 
isomer) and minor amounts of cyclopropanol 300 (Scheme 87). Since no chelation is possible in 
a TBAF mediated reaction, unlike the carbenoid mediated HCRL reaction, direct comparison to 
the diastereoselectivity of the HCRL reaction is not possible. 
	  
Scheme 88. TBAF rearrangement of TMS cyclopropanol 299 
  
The mixture of TMS cyclopropanol (299) was deprotected using TBAF and acetic acid to 
provide 300 (Scheme 88). The diastereomeric mixture of TMS cyclopropanols could not be 
separated by chromatography. The mixture of two diastereomers of cyclopropanol  was 
subjected to carbenoid to facilitate the rearrangement (Scheme 89). The cyclopropanols, when 
subjected to carbenoid, gave a complex reaction mixture similar to the HCRL reaction of the β-
keto imide 298. Trace amounts of bicyclic lactones 290 and 291 co-eluting with an unknown 
compound was observed. This study confirms that cyclopropanoxide rearrangement-
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Homologation-cyclopropanation of the β-keto imide derived from chiral oxazolidinone in the 
presence of TMSCl, followed by TBAF initiated rearrangement is a more efficient route for 
formation of bicyclic lactone.  
Since the TBAF rearrangement of the TMS ethers 299 yielded only bicyclic lactone 290, 
our next attempts focused on the synthesis and reaction of β-keto imide 301, which incorporated 
the chiral oxazolidinone produced from D-phenylalanine (Scheme 90). Compound 301 was 
generated by the Meldrum’s acid route as described earlier for the synthesis of 298.     
	  
Scheme 89. Deprotection of TMS cyclopropanol 299 to cyclopropanol 300 
	  
Scheme 90. Carbenoid facilitated rearrangement of cyclopropanol 300 
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The β-keto imide 301 was subjected to standard HCRL reaction conditions which utilized 
bis(iodomethyl)zinc(Scheme 91). The reaction was attempted using different numbers of  
equivalents of carbenoid to probe the feasibility of the reaction; However, β-keto imide 301, 
which contains the chiral oxazolidinone, gave a complex reaction mixture with each variation of 
the HCRL reaction. Therefore, the β-keto imide 301 was subjected to homologation-
cyclopropanation conditions in the presence of TMSCl to produce the TMS ether 302 (Scheme 
92). 
	  
Scheme 92. HCRL reaction of β-keto imide 301 
	  
Scheme 93. Synthesis of TMS cyclopropanol 302 
 
A VT 1H NMR experiment was again performed on TMS ether 302 at 25 oC, 55 oC and 
70 oC to differentiate the diastereomers from their rotameric forms (Figure 32). Overlapping 
resonances of the protons on the trimethylsilyl group of both the diastereomers made it 
challenging to accurately determine the diastereomeric ratio. Hence a MestReNova line fit 
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trimethyl group of the major and minor diastereomers at 0.25 and 0.19 ppm (70 oC) respectively 
were used to establish the diastereomeric ratio. A line fit was applied to each singlet of the two 
diastereomers, which established the area under the curve. The diastereomeric ratio of the TMS 
cyclopropanols 302 was 7:1 (Figure 33). Based on the facial selectivity in similar system 
observed by Lai and Taschner, the major diastereomer was assigned as 314.  
 
	  
Figure 32. VT 1H NMR (500 MHz) experiment of TMS cyclopropanol 302 a) 70 oC b) 55 oC 
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Figure 33. Determination of diastereomeric ratio of TMS cyclopropanol 302 using 
MestReNova line fitting 
 
The mixture of diastereomers of TMS ether 302 was treated with TBAF under anhydrous 
conditions to facilitate the rearrangement. Bicyclic lactone 291 (S, R isomer) and minor amounts 
of cyclopropanol 303 were produced from the TBAF-mediated rearrangement of TMS ether 302 
(Scheme 93).  
Similar to the β-keto imides derived from chiral oxazolidinone, β-keto imide derived 
from achiral oxazolidinone 289 was also treated with TMSCl in the presence of homologation-
cyclopropanation conditions to yield the TMS cyclopropanol 304 (Scheme 94). As expected the 
TMS cyclopropanol 304 was obtained in a diastereomeric ratio of 1:1 due to the lack of 
stereocontrol from achiral oxazolidinone. Tetra-n-butylammonium fluoride (TBAF)-mediated 
rearrangement of TMS cyclopropanol 304 yielded both diastereomers of bicyclic lactones 290 
and 291 (Scheme 94).   
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Scheme 94. TBAF rearrangement of TMS cyclopropanol 302 
	  




Scheme 96. TBAF rearrangement of β-keto imide to bicyclic lactones 
Effect of Evans auxiliary on the diastereoselectivity of formation of bicyclic lactones 290 
and 291 
 Rearrangement of cyclopropane is believed to play an important role in the HCRL 
reaction, influencing the diastereoselectivity of the reaction. The chiral oxazolidinone employed 
in the β-keto imide is expected to influence the enolate facial selectivity in the formation of the 
homoenolate and cyclization into the ketone. Hence trapping of the initial cyclopropoxide with 
TMSCl, followed by TBAF mediated rearrangement and acylation to provide the bicyclic 
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 The starting chiral β-keto imide 298 was subjected to homologation using 
bis(iodomethyl)zinc. Based on the previous studies by Lai and Lin, the Z-enolate of the imide 
305 would be predicted to be formed due to the 1,3-allylic strain of the E-enolate . The formation 
of homoenolate 306 would be directed by the chirality of the imide functionality. Based on the 
enolate facial selectivity reported by Lin and Lai, the alkylation of the Z-enolate with the 
carbenoid occurs on the opposite face compared to the substituent of the imide functionality 
resulting in the formation 307 (Scheme 96). The cyclopropoxide 307 then O-silylates with 
TMSCl to yield the TMS-protected cyclopropanol 308. However, there is crystallographic 
evidence to confirm the absolute stereochemistry of TMS cyclopropanol 308. The proposed 
structure of 308 is consistent with the facial selectivity reported by Taschner, who provided X-
ray crystallographic analysis data of TMS cyclopropanol 256 (Figure 68), in support of his 
assignment.  
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Scheme 97. Proposed diastereoselective mechanism for the formation of 308 
	  
Figure 34. Model of TBAF mediated rearrangement of TMS protected cyclopropanol  
 
Tetra-n-butylammonium fluoride (TBAF) mediated rearrangement followed by acylation 
of the diastereomeric mixture of 308 yielded only the bicyclic lactone 290. The model as 
depicted in Figure 34 is presented to account for this selectivity. The chiral auxiliary plays role 
in the initial facial selectivity of the enolate to form the TMS cyclopropanol and the established 
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model it was observed that both the established stereocenters from initial cyclopropanation and 
also the bulky phenyl carbamate-protecting group on the proline residue determines the 
diastereoselectivity of the cyclopropanoxide rearrangement. Similarly diastereoselectivity for the 
formation of the major diastereomer of TMS cyclopropanol from β-keto imide 301 and 
subsequent TBAF-mediated rearrangement of TMS cyclopropanol 302 followed by acylation to 
bicyclic lactone 291 was depicted in Scheme 97 and Figure 35.  
	  
Scheme 98. Proposed diastereoselective mechanism for the formation of 314 
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Summary of TBAF mediated rearrangement of TMS cyclopropanols 
The TMS cyclopropanol 299 was prepared in a 5:1 dr from β-keto imide 298, which 
incorporated the oxazolidinone produced from L-phenylalanine. Rearrangement was initiated by 
TBAF and yielded the bicyclic lactone (S,S isomer) 290. The TMS cyclopropanol 302 was 
prepared in a 7:1 dr from β-keto imide 301, which incorporated the oxazolidinone produced from 
D-phenylalanine. Rearrangement initiated by treatment with TBAF yielded the bicyclic lactone 
(S,R isomer) 291 (Table 9). The TMS cyclopropanol 304 derived from achiral oxazolidinone 
was obtained in a diastereomeric ratio of 1:1 and afforded both diastereomers of bicyclic lactones 
290 and 291 on TBAF rearrangement (Table 9). These reactions provide good evidence to 
confirm the role of chiral auxiliary in controlling the diastereoselectivity of the cyclopropanoxide 
rearrangement.  
 












R TMS cyclopropanol (dr) Bicyclic lactones(β- keto imide
298 5:1 290
301 7:1 291
289 1:1 290 and 291
298, R = (S)-benzyl
301, R = (R)-benzyl) 
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Tosyl Protected Proline derived β-keto imides 
Studies were focused on the role of proline’s protecting group in controlling the 
diastereoselectivity of the HCRL reaction. Sulfonamide protection of L-proline was achieved by 
treatment of L-proline with p-toluenesulfonyl chloride in aqueous sodium hydroxide (Scheme 
98). Tosyl-protected proline (317) was subjected to DCC coupling reaction to form an acylated 
Meldrum’s acid adduct as the DMAP salt (318).29 The DMAP salt of the Meldrum’s acid adduct 
was treated with DOWEX 50W-X2, to generate the free Meldrum’s acid adduct 319, which was 
refluxed in toluene with achiral oxazolidinone to afford the corresponding β-keto imide 278. β-
Keto imide 278 was then subjected to the HCRL reactions to obtain bicyclic lactones 279 and 
280 (Scheme 75). The bicyclic lactones 279 and 280 co-eluted together off the column similar to 
the results reported by Taschner.29 The spectral data of bicyclic lactones 279 and 280 was 
consistent with the spectral data reported by Taschner. 
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Chiral β-keto imide 320, derived from D-phenylalanine was synthesized by refluxing free 
acid 319 with chiral oxazolidinone in toluene (Scheme 99). Chiral β-keto imide 320 was 
subjected to homologation cyclopropanation in the presence of TMSCl. The TMS cyclopropanol 
321 was purified by preparative thin layer chromatography. However, the purified TMS 
cyclopropanol 321 contained an unknown impurity. The impurity was predicted as the other 
possible TMS ether, however, more analysis is needed to confirm the identity of the unknown 
impurity. Mower observed some decomposition products when tosyl-protected proline systems 
were subjected to the carbenoid conditions.32. The TMS cyclopropanol 321 along with the 
impurity was subjected to TBAF rearrangement (Scheme 100). Tetra-n-butylammonium fluoride 
(TBAF)-mediated rearrangement of the TMS cyclopropanol 321 afforded only one isomer of the 
bicyclic lactone as a white solid. Based on 1H NMR analysis, this compound was identical to the 
minor bicyclic lactone obtained by Taschner in the HCRL reaction of β-keto imide 278 (Scheme 
100 and Figure 36). Since the relative stereochemistry of the major and minor bicyclic lactones 
derived from HCRL reaction of  321 are unknown, an X-ray crystal structure of bicyclic lactone 
obtained from TBAF rearrangement of TMS cyclopropanol 321 would be of great value. Efforts 
to grow the crystal structure of the bicyclic lactone obtained from 321 are underway. Since the 
TMS cyclopropanol 321 is impure, interpretation of the selectivity in the formation of the 
bicyclic lactone via the TBAF rearrangement will be difficult. More work is needed to 
understand the selectivity of the HCRL reaction of tosyl-protecting-proline substrate. 
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Scheme 100. Synthesis of chiral β-keto imide 320 	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  Figure 36.  1H NMR of a) mixture of bicyclic lactones b) bicyclic lactone obtained from the 
TBAF rearrangement.  
Conclusions and Future Work 
 A novel cyclopropanol peptide isostere possessing H-bonding capability has been 
designed in the Zercher group. Sequential homologation-cyclopropanation-rearrangement-
lactonization reactions (HCRL) have been utilized to form bicyclic lactones, which upon opening 
with amines provide products that contain a cyclopropanol moiety and are proposed to serve as 
peptide isostere. A HCRL reaction of β-keto imide, which incorporated a achiral oxazolidinone, 
was followed by treatment with benzyl amine, which resulted in the formation of the 
cyclopropanol containing peptide isostere. The structure of the major product was determined by 
X-ray analysis, which allowed the assignment of the relative stereochemistry of the cyclopropane 
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reaction of β-keto imides that incorporated chiral oxazolidinones did not afford bicyclic lactones. 
Therefore, an alternative approach that involved intermediate formation of a TMS cyclopropanol 
was employed. Tetra-n-butylammonium fluoride (TBAF)-mediated rearrangement of TMS 
cyclopropanol provided good evidence for the role of chiral auxiliary in controlling the 
diastereoselectivity of the bicyclic lactone formation. 
 With the ability to open the bicyclic lactones, various amine residues can be used to 
establish a library of peptide isosteres. The α-carbon of bicyclic lactones can be functionalized to 
incorporate substituents that would mimic amino acid side chains in the peptide isosteres.  
 






 	  	  	  	  	  










Anhydrous solvents dichloromethane (DCM), methanol, tetrahydrofuran (THF), toluene, 
dimethylformamide (DMF) are obtained from EMD Millipore OmniSolv and dispensed the 
solvent from Innovative Technology Inc. solvent delivery system and stored over 3 Å and 4 Å 
molecular sieves. Methanol was stored over 3 Å molecular sieves. 
 
Reagents and Reactions 
All reagents are obtained from commercial sources and were used as received unless specified in 
detail. Reaction glassware and magnetic stir bars were stored in an oven at 200 oC. Sigma-
Aldrich rubber septa and Teflon-coated magnetic stir bars were used unless specified differently. 
Nitrogen gas was introduced into the reaction vessel through a Tygon® tube with glass inlet 
adapter or a needle. Henke Sass Wolf Norm-Ject® plastic syringes and oven dried needles were 
used for volumetric addition of reagents. 
 
Chromatography 
Flash column chromatography was performed with Silica-P Flash Silica Gel with 40-63 µm 
particle size. Thin Layer Chromatography (TLC) analysis was performed on Whatman glass-
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backed Silica Gel 60 Å 250-µmthickness with fluorescent indicators for UV detection. 
Anisaldehyde and phosphomolybdic acid stains were used in certain cases for TLC analysis. 
Preparative Thin Layer chromatography was accomplished with the use of Analtech Uniplate 
Silica gel GF 1000 microns with UV 254 glass-backed plates. 
Spectroscopy 
Nuclear Magnetic Resonance (NMR) spectroscopy was achieved using a Varian Mercury 
spectrometer operating at 400 or 500 MHz for 1H and 100 or 126 MHz for 13C spectroscopy. All 
carbon spectra were proton-decoupled. All 1H spectra were referenced relative to TMS (δ 0 ppm) 
unless otherwise specified. All 13C resonances were referenced to CDCl3 (δ 77.16 ppm) or TMS 
(δ 0 ppm). The 1H and 13C NMR run in C6D6 are referenced relative to TMS. Infrared 
spectroscopy (IR) was conducted using a Thermo Nicolet iS10 FTIR using a diamond ATR 
probe. Diastereomeric ratios were calculated from integrations obtained by applying a 
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DETAILED EXPERIMENTAL SECTION 
 
(R)-5-Methyldihydrofuran-2(3H)-one (181) 
An oven-dried 500-mL three-necked round-bottomed flask equipped with a magnetic stir 
bar, nitrogen gas adaptor, reflux condenser and a rubber septum was charged with anhydrous 
methanol (115 mL). Freshly cut sodium metal (100 mmol, 2.29 g), rinsed in hexanes was added 
slowly in small portions to the methanol. The solution was then cooled to 0 oC using an ice-water 
bath and then freshly distilled dimethyl malonate (100 mmol, 11.5 mL) dissolved in anhydrous 
methanol (12 mL) was added dropwise to the reaction mixture while stirring and was heated to 
reflux for 0.5 h. The solution was then cooled back to room temperature at which time R-
propylene oxide (20 mmol, 1.4 mL) dissolved in anhydrous methanol (7 mL) was added via 
syringe in one portion to the stirred solution of the anion of dimethyl malonate. The reaction 
mixture was then stirred for 20 h at room temperature. The reaction was then heated at 50 oC 
using an oil bath for 8 h and then heated to reflux for 20 h, at which time the reaction mixture 
turned yellow. The reaction was then quenched with acetic acid (6 mL) and then stirred for 20 
min. The reaction mixture was then concentrated in vacuo to yield a yellow residue, which was 
then dissolved in water (31 mL) and extracted with diethyl ether (3 x 20 mL). The combined 
organic extracts were dried over sodium sulfate (ca. 5 g) gravity filtered and concentrated via 
rotary evaporation (10 mmHg, 21 oC) to afford yellow oil, which contained both the lactone ester 
and excess dimethyl malonate. The major portion of the dimethyl malonate was removed by 
fractional distillation and the remaining reaction mixture containing lactone ester was refluxed 
for 10 h in DMSO: H2O (96/4, v/v, 25 mL) containing lithium chloride (3.98 g, 94 mmol). The 
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reaction was monitored by TLC (Rf = 0.51, 1:1 EtOAc - hexane). The cooled reaction mixture 
was diluted with brine (25 mL) and then extracted with dichloromethane (2 x 50 mL). The 
combined organic extracts were washed with brine (50 mL), dried over sodium sulfate (ca.10 g), 
gravity filtered and concentrated by rotary evaporation (10 mmHg, 21 oC) to afford the crude 
product as brown oil.  The crude product was purified by flash column chromatography on silica, 
eluting with a gradient mobile phase of 2%,4%,6%,8%,10%,15%,20%25%,30% diethyl ether 
and hexane. The pure  (R)-γ-valerolactone was obtained as a colorless oil (0.80 g, 40%). 1H 
NMR (400 MHz, CDCl3) 1H NMR (400 MHz, CDCl3) δ 4.65 (m, 1H), 2.38 (m, 2H), 1.84 (m, 
1H), 1.90 - 1.78 (m, 1H), 1.42 (d, J = 6.3 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ 177.5, 77.4, 
29.8, 29.2, 21.2. 
(R)-tert-Butyldimethylsilyl 4-((tert-butyldimethylsilyl)oxy)pentanoate (190) 
An oven-dried 100-mL round-bottomed flask equipped with a magnetic stir bar and 
rubber septum was charged with (R)-(+)-γ-valerolactone (0.74 g, 7.4 mmol) in a mixture of water 
(4 mL) and dioxane (4 mL). Sodium hydroxide (0.30 g, 7.4 mmol) was added to the reaction 
mixture, which was stirred at room temperature for 30 min. The reaction mixture was 
concentrated on a rotary evaporator until a white solid was formed. The white solid was then 
dried on high vacuum pump for 3 h. The dried white solid was suspended in distilled dimethyl 
formamide to which tert-butyldimethylsilylchloride (3.36 g, 22.3 mmol), imidazole (2.02 g, 29.7 
mmol) and dimethylaminopyridine (0.45 g, 3.72 mmol) were added. The reaction mixture was 
stirred overnight at room temperature and then at 50 oC for 1 h. The reaction was quenched with 
water (4.5 mL) and extracted with diethyl ether (3 x 10 mL). The combined ether extracts were 
washed with 10% citric acid (10 mL), brine (10 mL) and then dried over anhydrous magnesium 
sulfate, vacuum filtered and concentrated by rotary evaporation to afford the crude product as 
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yellow oil. The crude product was purified by flash column chromatography on silica, eluting 
with 2 : 1 (hex : EtoAc, Rf = 0.61) (2.42 g, 94%). 1H NMR (500 MHz, CDCl3) δ 3.83 (sex, J = 
6.0 Hz, 1H), 2.43 - 2.30 (m, 2H), 1.78 – 1.62 (m, 2H) 1.11 (d, J = 6.2 Hz, 3H), 0.87 (s, 9H), 0.85 
(s, 9H), 0.05 (s, 6H), 0.02 (s, 3H), 0.01 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 184.0, 72.3, 39.0, 
35.0, 30.7, 30.5, 28.4, 22.8, 22.8,1.2, 0.4, 0.0. IR (neat) ν 2955, 2857, 1710, 1472, 1361, 1253, 
1136, 1089 cm-1. 
(R)-4-((tert-Butyldimethylsilyl)oxy)pentanoic acid (191) 
An oven-dried 250-mL round-bottomed flask equipped with a magnetic stir bar was 
charged with methanol (90.2 mL) and cooled to 0 oC in an ice-water bath. Bis-TBDMS 
derivative 190 (3.14 g, 9.03 mmol) dissolved in methanol (10 mL) was added via an oven-dried 
needle in one portion. Potassium carbonate (3.12 g, 22.6 mmol) dissolved in water (27 mL) was 
added to the above reaction mixture and the reaction mixture stirred at room temperature for 4 h. 
The solvent was removed via rotary evaporation (10 mmHg, 45 oC) to afford a yellow residue. 
The crude residue was then dissolved in water (45 mL), cooled in an ice-water bath and acidified 
to pH 4 with 10% aqueous citric acid (ca. 40 mL) and extracted with ethyl acetate (4 x 40 mL). 
The organic layers were combined, dried over sodium sulfate (ca. 30 g), gravity filtered and 
concentrated in vacuo to yield the crude acid  as yellow oil (1.57 g, 75 %).  1H NMR (400 MHz, 
CDCl3) δ 3.88 (m, 1H), 2.51 – 2.36 (m, 2H), 1.84 – 1.65 (m, 2H), 1.15 (d, J = 6.3 Hz, 3H), 0.89 
(s, 9H), 0.06 (s, 3H), 0.05 (s, 3H); 13C NMR (101 MHz, CDCl3) δ, 184.4, 72.3, 38.8, 35.0, 30.6, 
28.4, 22.9, 0.4, 0.0. IR (neat) ν 1563, 1356, 1004, 828 cm-1. 
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4-(Dimethylamino)pyridin-1-ium (R)-4-((tert-butyldimethylsilyl)oxy)-1-(2,2-dimethyl-4,6-
dioxo-1,3-dioxan-5-ylidene)pentan-1-olate DMAP salt (192) 
An oven-dried 250-mL round-bottomed flask equipped with a magnetic stir bar and 
nitrogen gas inlet was charged with acid 191 (1.57 g, 6.75 mmol) in dry dichloromethane (12 
mL) and cooled to 0 oC in an ice-water bath. Dicyclohexylcarbodiimide (1.39 g, 6.75 mmol) was 
then added to the above reaction mixture and stirred at 0 oC for 30 min. Meldrums acid (0.97 g, 
6.75 mmol) and 4-(dimethylamino)pyridine (0.82 g, 6.75 mmol) were added to the solution as 
solids in one portion and the reaction was allowed to warm to room temperature and stir for 12 h 
at which time dicyclohexylurea was removed by vacuum filtration as a white solid. The filtrate 
was concentrated in vacuo and dried on a high vacuum pump (1 mmHg, 21 oC) to yield the crude 
DMAP salt  as a yellowish green solid (Rf = 0.25, 1:1 EtOAc – hexane). The crude DMAP salt 
was proceeded to the next step without any purification. 1H NMR (500 MHz, CDCl3) δ 8.34 - 
8.31 (m, 2H), 6.65 - 6.60 (m, 2H), 3.90 (h, J = 6.1 Hz, 1H), 3.17 (s, 6H), 3.00 (m, 2H), 1.86 - 
1.71 (m, 2H), 1.67 (s, 6H), 1.17 (d, J = 6.0 Hz, 3H), 0.89 (s, 9H), 0.08 (s, 3H), 0.06 (s, 3H). 13C 
NMR (126 MHz, CDCl3) δ 203.6, 170.8, 160.9, 147.8, 110.9, 73.4, 44.3, 42.8, 40.1, 38.5, 32.2, 
30.9, 30.5, 28.3, 22.8, 4.5. IR (CH2Cl2) ν 2927, 1641, 1598, 1555, 1442, 1372, 1262, 1209, 1019 
cm-1. 
(R)-4-((tert-Butyldimethylsilyl)oxy)-1-(2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)pentan-
1-olate (193) 	  
An oven-dried 100-mL round-bottomed flask equipped with a magnetic stir bar and 
nitrogen gas inlet was charged with anhydrous dichloromethane (50 mL), DMAP salt (3.24 g, 
6.75 mmol) and anhydrous DOWEX 50WX2 ion exchange resin (10.1 g, 1.5 g for 1 mmol of 
DMAP salt). The solution was stirred at room temperature for 1 h. The resin was removed by 
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filtration and the filtrate was concentrated in vacuo to afford the free acid as a greenish yellow 
oil (Rf = 0.12, 1:1 EtOAc-hexane), which was carried on to the next step without purification. 1H 
NMR (400 MHz, CDCl3) δ 1H NMR (400 MHz, CDCl3) δ 3.92 (sextet, 1H), 3.21-3.06 (m, 2H), 
1.87-1.75 (m, 2H), 1.73 (s, 6H), 1.19 (d, J = 6.1 Hz, 3H), 0.89 (s, 9H), 0.07 (s, 3H), 0.06 (s, 3H) 
(R)-1-((S)-4-Benzyl-2-oxooxazolidin-3-yl)-6-((tert-butyldimethyl silyl)oxy) heptane 1,3-dione 
(194) 
An oven-dried 250-mL round-bottomed flask, equipped with a magnetic stir bar, reflux 
condenser and nitrogen gas adaptor was charged with free acid 193 (3.4 mmol, 1.205 g) in 
anhydrous toluene (60 mL). Chiral oxazolidinone 161 (4.0 mmol, 0.71 g) was added in one 
portion as a solid to the reaction mixture and was heated to reflux for 4 h. The reaction was 
monitored by TLC (hexane:EtOAc 1:1, Rf = 0.57). The reaction mixture was cooled and then 
washed with water (30 mL) and brine (30 mL). The organic layer was concentrated in vacuo to 
yield crude product as yellow oil. The crude product was purified by flash column 
chromatography on silica, eluting with a gradient mobile phase of 
2%,4%,6%,8%,10%,12%,14%,16%,18%,20%,25%,30% diethyl ether and hexane. The titled 
compound 194 was obtained as light yellow colored solid containing both keto-enol forms (0.70 
g, 48%). 1H NMR keto form (400 MHz, CDCl3) δ 7.38 - 7.20 (m, 5H), 4.76 – 4.68 (m, 1H), 4.26 
- 4.14 (m, 2H), 4.14 - 4.00 (AB, 2H), 3.85 (sextet, J = 6.2 Hz, 1H), 3.39 (dd, J = 13.6, 3.4 Hz, 
1H), 2.79 (dd, J = 13.5, 9.8 Hz, 1H), 2.72 - 2.54 (m, 2H), 1.84 - 1.62 (m, 2H), 1.13 (d, J = 6.1 
Hz, 3H), 0.89 (s, 9H), 0.05 (s, 3H), 0.01 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 208.1, 171.3, 
158.4, 139.9, 134.2, 133.7, 132.1, 72.2, 71.1, 59.8, 55.4, 43.7, 42.4, 37.5, 30.6, 28.4, 22.8, 0.40, 
0.00. IR (neat) ν 2955, 2852, 1761, 1690, 1396, 1089, 990, 834 cm-1. The enol form is identified 
through the presence of the proton resonances at 6.53 and 13.6 ppm.  




An oven-dried 100-mL round-bottomed flask equipped with a magnetic stir bar and 
nitrogen gas inlet was charged with dry dichloromethane (14 mL) and cooled to 0 oC in an ice-
water bath. Neat diethylzinc (0.37 mL, 3.6 mmol) was added in one portion via an oven-dried 
needle followed by dropwise addition of diiodomethane (0.29 mL, 3.6 mmol) over the course of 
5 min. The reaction was allowed to stir at 0 oC for 10 min at which time a milky white 
suspension was formed. tert-Butyldiphenylsilyl protected aldehyde 209 (0.43 g, 1.3 mmol) in dry 
dichloromethane (2 mL) was added via syringe in one portion to the carbenoid at 0 oC.  β-Keto 
imide 194 (0.52 g, 1.2 mmol) in dry dichloromethane (3 mL) was added by syringe to the 
reaction mixture in one portion at 0 oC and stirred at the same temperature for 1 h. The reaction 
mixture was stirred at room temperature for 1 h. The reaction mixture was quenched with 
saturated ammonium chloride (ca. 6 mL) and extracted with dichloromethane (3 x 15 mL). The 
organic layers were pooled, dried with sodium sulfate (ca. 10 g), gravity filtered and 
concentrated invacuo to afford a viscous brown oil. The crude mixture was purified by  flash 
column chromatography on silica, eluting with a gradient mobile phase of 
2%,5%,7%,8%,10%,12%,15%,20%,25%,30%,35%,40%,45%,50%,55%,60%,65%,70%,75%,80
% diethyl ether and hexane (hexane:EtOAc 1:1, Rf = 0.64) to afford the title compound XX as a 
mixture of open-hemiacetal isomers as a yellow oil (0.41 g, 44%).  1H NMR (400 MHz, CDCl3) 
δ 7.69 - 7.57 (m, 4H), 7.43 - 7.07 (m, 11H), 4.73 - 4.54 (m, 2H), 4.44 - 4.31 (m, 1H), 4.30 - 4.00 
(m, 4H), 3.89 - 3.73 (m, 2H), 3.73 - 3.57 (m, 2H), 3.35 - 3.05 (m, 3H), 2.82 - 2.61 (m, 2H), 2.60 - 
2.39 (m, 2H), 2.28 (ddd, J = 10.2, 3.3, 10.4 Hz, 1H), 1.97 - 1.42 (m, 8H), 1.15 - 1.04 (m, 3H), 
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1.01 (s, 9H), 0.85 (s, 9H), 0.04 (s, 3H), 0.02 (s, 3H). 13C NMR (101 MHz, CDCl3) δ13C NMR 
(101 MHz, CDCl3) δ 215.3, 214.6, 181.2, 179.2, 175.8, 162.3, 158.5, 157.7, 141.2, 140.3, 139.6, 
138.7, 138.3, 134.4, 134.3, 134.2, 134.1, 133.7, 133.6, 133.5, 132.4, 132.3, 131.6, 130.2, 111.6, 
111.1, 76.1, 73.3, 72.3, 71.4, 71.1, 70.6, 69.4, 68.7, 68.4, 65.1, 62.2, 60.1, 51.9, 48.5, 45.7, 45.07, 
44.4, 44.0, 43.7, 42.5, 41.1, 40.5, 39.1, 39.0, 37.9, 36.7, 36.4, 35.0, 33.8, 33.6, 31.6, 30.65, 28.5, 
26.8, 25.8, 24.3, 24.0, 22.8, 20.0, 18.9, 0.3, 0.1. IR (CH2Cl2) ν 1780, 1698, 1386, 1251, 1095, 
833, 773 cm-1. 
 
Spirocyclization  
An oven-dried 100-mL round-bottomed flask equipped with a magnetic stir bar and 
nitrogen gas inlet was charged with aldol product 210 (0.87 g, 1.12 mmol) in dry 
dichloromethane (10 mL). Camphorsulfonic acid (0.28 g, 1.2 mmol) was added as a solid in one 
portion to the reaction mixture and stirred at room temperature for 18 h. The crude reaction 
mixture was filtered through a plug of celite and the dichloromethane was removed by rotary 
evaporation to yield a yellow oil. The crude reaction mixture was purified by flash column 
chromatography on silica, eluting with a gradient mobile phase of  2%, 4%, 6%, 8%, 10%, 12%, 
15%, 20%, 25%, 27%, 30%, 40% and 45% ethyl acetate and hexane. Spiroketal  (214) eluted 
with 30% ethyl acetate and hexane (Rf  = 0.63, 1:1 EtOAc - hexane) followed by spiroketal  
(215) with 35% ethyl acetate and hexane (Rf = 0.57, 1:1 EtOAc - hexane). Spiroketal  (212) 
eluted with 40% ethyl acetate (Rf = 0.51, 1:1 EtOAc - hexane) and hexane followed by spiroketal 
(213) with 45% ethyl acetate and hexane (Rf = 0.42, 1:1 EtOAc - hexane) (overall 30% yield, 90 
mg of spiroketal 3, 28 mg spiroketal 4).  
	   131	  
(S)-4-Benzyl-3-((2R,3R,5R,7R)-2-(3-((tert-butyldiphenylsilyl)oxy)propyl)-7-methyl-1,6-
dioxaspiro[4.4]nonane-3-carbonyl)oxazolidin-2-one (212) 
1H NMR (500 MHz, CDCl3) 1H NMR (400 MHz, CDCl3) δ 7.74 - 7.63 (m, 4H), 7.50 - 7.11 (m, 
11H), 4.72 – 4.62 (m, 1H), 4.41 - 4.05 (m, 6H), 3.76 – 3.64 (m, 2H), 3.24 (dd, J = 13.3, 3.4 Hz, 
1H), 2.72 (dd, J = 13.4, 9.6 Hz, 1H), 2.50 – 2.30(m, 2H), 2.17 - 2.05 (m, 2H), 1.89 - 1.71 (m, 
3H), 1.70 – 1.55 (m, 1H), 1.49 - 1.36 (m, 1H), 1.18 (d, J = 6.2 Hz, 3H), 1.04 (s, 9H). 13C NMR 
(101 MHz, CDCl3) δ 174.0, 153.2, 135.8, 135.3, 134.3, 129.7, 129.6, 129.2, 127.8, 127.6, 115.3, 
82.8, 74.4, 66.3, 64.1, 55.5, 48.5, 40.3, 38.1, 35.7, 32.9, 32.0, 29.7, 27.1, 21.5, 19.4. DEPT-135 
(101 MHz, CDCl3) δ 135.8, 129.7, 129.6, 129.2, 127.8, 127.6, 82.9, 74.5, -66.3, -64.1, 55.6, 
48.5, -40.4, -38.2, -35.8, -33.0, -32.0, -29.7, 27.1, 21.5, 19.5. IR (CH2Cl2) ν 2928, 1779, 1697, 




1H NMR (400 MHz, CDCl3) 1H NMR (400 MHz, CDCl3) δ 7.69 - 7.64 (m, 4H), 7.43 - 7.15 (m, 
11H), 4.68 (ddt, J = 10.4, 6.9, 3.5 Hz, 1H), 4.62 – 4.56 (m, 1H), 4.33 - 4.06 (m, 4H), 3.80 (ddd, J 
= 11.1, 8.3, 6.9 Hz, 1H), 3.73 - 3.64 (m, 2H), 3.29 (dd, J = 13.3, 3.4 Hz, 1H), 2.69 (dd, J = 13.3, 
9.8 Hz, 1H), 2.57 (dd, J = 13.3, 11.1 Hz, 1H), 2.15 (dd, J = 13.4, 6.9 Hz, 1H), 2.12 - 2.00 (m, 
2H), 1.96 - 1.86 (m, 1H), 1.83 - 1.56 (m, 4H), 1.28 (d, J = 6.2, 3H), 1.03 (s, 9H). 13C NMR (101 
MHz, CDCl3) δ 173.1, 153.3, 135.7, 135.4, 134.2, 129.7, 129.6, 129.1, 127.8, 127.5, 113.7, 79.1, 
76.4, 66.4, 63.9, 55.6, 48.1, 40.6, 38.1, 37.1, 32.5, 30.9, 29.5, 27.1, 23.5, 19.4. IR (CH2Cl2) ν 
2931, 1776, 1687, 1384, 1165, 1104, 815 cm-1 
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(2R,3R,5R,7R)-2-(3-((tert-Butyldiphenylsilyl)oxy)propyl)-7-methyl-1,6-
dioxaspiro[4.4]nonane-3-carboxylic acid (216)  
An oven-dried 100-mL round-bottomed flask equipped with a magnetic stir was charged 
with 0.05 M solution of spiroketal 212 (90 mg, 0.14 mmol) in THF : H2O (3 : 1) mixture (5 mL) 
and cooled to 0 oC in an ice-water bath. Hydrogen peroxide (30 % by weight in water) (0.07 mL, 
0.56 mmol) was added to the reaction mixture at 0 oC via syringe over a 5 min period. 
Anhydrous lithium hydroxide (7 mg, 0.28 mmol) was added as a white solid in one portion to the 
above reaction mixture at 0 oC. The reaction mixture was then warmed to room temperature and 
stirred for 12 h. The reaction mixture was quenched with 1M sodium sulfite (5 mL) and stirred 
for 20 min. The bulk of the THF was removed via rotary evaporation (1 mmHg, 30 oC). The 
resulting mixture was basified with 10% sodium bicarbonate to pH 12 and extracted with 
dichloromethane (3 x 10 mL) to remove the oxazolidinone. The aqueous layer was acidified to 
pH 1 with 6 M hydrochloric acid and extracted with ethyl acetate (3 x 5 mL), concentrated in 
vacuo to recover the carboxylic acid. However the NMR of the crude reaction mixture showed 
the presence of both oxazolidinone and carboxylic acid 216 in dichloromethane extracts and only 
traces of acid in the ethyl acetate layer. The dichloromethane extracts were combined, 
concentrated in vacuo and was purified by flash column chromatography on silica, eluting with a 
gradient mobile phase of 5%, 10%, 20%, 30% methyl tert butyl ether (MTBE) and hexane (Rf = 
0.13, 2 :1 hexane - MTBE) (0.051 g, 76% yield). The carboxylic acid XX was eluted with 30 % 
MTBE : hexane.   1H NMR (400 MHz, CDCl3) δ 7.73 - 7.63 (m, 4H), 7.56 - 7.33 (m, 6H), 4.27 - 
4.13 (m, 2H), 3.72 - 3.64 (m, 1H), 3.12 - 3.04 (q, J = 8.8 Hz, 1H), 2.37 - 2.28 (m, 2H), 2.16 - 
1.97 (m, 2H), 1.83 - 1.56 (m, 3H), 1.50 - 1.29 (m, 5H), 1.18 (d, J = 6.2 Hz, 3H), 1.04 (s, 9H). IR 
(CH2Cl2) ν 3100, 1707, 1434, 1412, 1278, 1110, 928 cm-1 
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(2R,3R,5S,7R)-2-(3-((tert-Butyldiphenylsilyl)oxy)propyl)-7-methyl-1,6-
dioxaspiro[4.4]nonane-3-carboxylic acid (217) 
An oven-dried 100-mL round-bottomed flask equipped with a magnetic stir was charged 
with 0.05 M solution of spiroketal 213 (28 mg, 0.04 mmol) in THF : H2O (3 : 1) mixture (2 mL) 
and cooled to 0 oC in an ice-water bath. Hydrogen peroxide (30 % by weight in water) (1.6 µL, 
0.16 mmol) was added to the reaction mixture at 0 oC via syringe over a five minute period. 
Anhydrous lithium hydroxide (2 mg, 0.08 mmol) was added as a white solid in one portion to the 
above reaction mixture at 0 oC. The reaction mixture was warmed to room temperature and 
stirred for 12 h. The reaction mixture was quenched with 1M sodium sulfate (2 mL) and stirred 
for 20 min. The bulk of the THF was removed via rotary evaporation (1 mmHg, 30 oC). The 
resulting mixture was basified with 10% sodium bicarbonate to pH 12 and extracted with 
dichloromethane (3 x 5 mL) to remove the oxazolidinone. The aqueous layer was acidified to pH 
1 with 6 M hydrochloric acid and extracted with ethyl acetate (3 x 5 mL) to recover the 
carboxylic acid. However, NMR showed the presence of both oxazolidinone and carboxylic acid 
in dichloromethane extracts and only traces of acid in the ethyl acetate layer. The carboxylic acid 
217 was purified by flash column chromatography on silica, eluting with a gradient mobile phase 
of 5%, 10%, 20%, 30% methyl tert-butyl ether (MTBE) and hexane (Rf = 0.13, 2 : 1 hexane - 
MTBE) (0.020 g, 90% yield). The carboxylic acid 217 was eluted with 30 % MTBE : hexane. 
The spectra showed minor impurities. 1H NMR (400 MHz, CDCl3) δ 7.73 - 7.62 (m, 4H), 7.55 - 
7.32 (m, 6H), 4.34 - 4.11 (m, 3H), 3.71 - 3.64 (m, 2H), 2.80 (ddd, J = 10.2, 6.1, 3.9 Hz, 1H), 2.37 
- 2.19 (m, 2H), 2.16 - 1.94 (m, 3H), 1.85 - 1.55 (m, 5H), 1.30 (d, J = 6.2, 3H), 1.04 (s, 9H). 13C 
NMR (101 MHz, CDCl3) δ 175.9, 135.7, 134.1, 129.7, 127.8, 114.4, 80.5, 63.8, 49.5, 38.4, 35.4, 
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32.6, 31.9, 29.9, 28.7, 27.1, 23.0, 19.4.  IR (CH2Cl2) ν 3109, 1705, 1434, 1412, 1278, 1110, 928 
cm-1 
 
Barton decarboxylation of carboxylic acid of spiroketal 3 
 An oven-dried 100-mL round-bottomed flask, equipped with a magnetic stir bar and 
nitrogen gas inlet was charged with carboxylic acid XX (0.051 g, 0.11 mmol) in anhydrous 
dichloromethane (3 mL). Oxalyl chloride (0.033 mL, 0.38 mmol) was slowly added to the 
reaction mixture and stirred at room temperature for 50 min. The solvent and excess oxalyl 
chloride was removed using a rotary evaporator and the residual oil was dried on high vacuum 
line (1.0 torr) for 10 min. 
Decarboxylation  
 Commercially available chloroform (ACS grade) was washed with water, dried over 
potassium carbonate and distilled over P2O5 under nitrogen and then stored in 3Å MS in dark 
until used. 1-Hydroxypyridine-2(1H)-thione sodium salt was dried on high vacuum pump. 
 An oven-dried 50-mL two-necked round-bottomed flask, equipped with a magnetic stir 
bar, nitrogen gas inlet and a reflux condenser, was charged with 1-hydroxypyridine-2(1H)-thione 
sodium salt (0.02 g, 0.13 mmol) and DMAP (4 mg, 0.003 mmol) in distilled chloroform (2 mL). 
The resulting white suspension was refluxed. The acid chloride prepared above was dissolved in 
distilled chloroform (4 mL) and added dropwise via syringe with concomitant irradiation from 
halogen lamp (200 W) over a 20 min period. The reaction mixture turned from white suspension 
to light yellow colored clear solution on addition of the acid chloride. The mixture was refluxed 
for 150 min and monitored by TLC. The reaction mixture was cooled to room temperature, 
quenched with 1M hydrochloric acid (5 mL) and extracted with dichloromethane (3 x 5 mL). 
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The organic layers were combined, washed with brine (5 mL), dried over sodium sulfate, filtered 
and concentrated in vacuo. The crude reaction mixture was purified by preparative thin layer 
chromatography, eluting with a mobile phase of 20% EtOAc – hexane  to afford the desired 
spiroketals 92 (Rf = 0.56, 3 : 1 hexane – ethyl acetate) (19 mg, 40% yield) and 93 (Rf = 0.53, 3 :1 




1H NMR (500 MHz, CDCl3) δ 7.68 - 7.64 (m, 4H), 7.44 - 7.34 (m, 6H), 4.20 (sextet, J = 6.3 Hz, 
1H), 4.00 - 3.97 (m, 1H), 3.67 (t, J = 6.3 Hz, 2H), 2.16 - 1.88 (m, 6H), 1.80 - 1.53 (m, 6H), 1.20 
(d, J = 6.2 Hz, 3H), 1.04 (s, 9H). 13C NMR (126 MHz, CDCl3) δ 135.5, 134.1, 129.5, 127.6, 
114.4, 79.7, 73.7, 64.00, 36.3, 35.5, 33.7, 31.8, 30.8, 29.3, 26.9, 21.3, 19.2. DEPT-135 (101 
MHz, CDCl3) δ 135.6, 134.1 29.5, 127.5, 114.4 79.7, 73.7, -64.0, -36.3, -35.1, -33.7, -31.8, -




1H NMR (400 MHz, CDCl3) δ 7.69 - 7.63 (m, 4H), 7.45 - 7.33 (m, 6H), 4.22 - 4.06 (m, 2H), 3.72 
- 3.62 (m, 2H), 2.16- 1.86 (m, 6H), 1.77 - 1.42 (m, 6H), 1.26 (d, J = 6.2Hz, 3H), 1.04 (s, 9H).  
13C NMR (101 MHz, CDCl3) δ 135.6, 134.1, 129.5, 127.6, 114.5, 77.7, 75.7, 63.9, 36.7, 35.1, 
32.6, 32.0, 30.0, 29.0, 26.9, 22.8, 19.2. 
 
 
	   136	  
Barton decarboxylation of carboxylic acid of spiroketal 4 
 An oven-dried 100-mL round-bottomed flask, equipped with a magnetic stir bar and 
nitrogen gas inlet was charged with carboxylic acid XX (0.020 g, 0.04 mmol) in anhydrous 
dichloromethane (2 mL). Oxalyl chloride (0.012 mL, 0.14 mmol) was slowly added to the 
reaction mixture and stirred at room temperature for 50 min. The solvent and excess oxalyl 
chloride were removed using a rotary evaporator and the residual oil was dried on high vacuum 
line (1.0 torr) for 10 min. 
Decarboxylation  
 Commercially available chloroform (ACS grade) was washed with water, dried over 
potassium carbonate and distilled over P2O5 under nitrogen and then stored in 3A MS in dark 
until used. 1-Hydroxypyridine-2(1H)-thione sodium salt was dried on high vacuum pump. 
 An oven-dried 50-mL two-necked round-bottomed flask, equipped with a magnetic stir 
bar, nitrogen gas inlet and a reflux condenser was charged with 1-hydroxypyridine-2(1H)-thione 
sodium salt (7 mg, 0.05 mmol) and DMAP (2 mg, 0.001 mmol) in distilled chloroform (2 mL). 
The resulting white suspension was refluxed. The acid chloride prepared above was dissolved in 
distilled chloroform (2 mL) was added dropwise via syringe with concomitant irradiation from 
halogen lamp (200 W) over a 20 min period. The reaction mixture turned from white suspension 
to light yellow colored clear solution on addition of the acid chloride. The mixture was refluxed 
for 2.5 h and monitored by TLC. The reaction mixture was cooled to room temperature, 
quenched with 1M hydrochloric acid (3 mL) and extracted with dichloromethane (3 x 3 mL). 
The organic layers were combined, washed with brine, dried over sodium sulfate, filtered and 
concentrated in vacuo. The crude reaction mixture was purified by preparative thin layer 
chromatography, eluting with a mobile phase of 20% EtOAc – hexane to afford the desired 
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spiroketals 206 and 207 as a yellow oil. The spectral data and yields of spiroketals 206 and 207 
were identical to the ones reported earlier. 
4-((tert-Butyldimethylsilyl)oxy)butan-1-ol (180)  
An oven-dried 100-mL round-bottomed flask equipped with a magnetic stir bar and 
nitrogen gas inlet was charged with anhydrous THF (24 mL). Sodium hydride (11.2 mmol, 0.45 
g, 60% wt in mineral oil) was washed with hexane under the bed of nitrogen and added to the 
reaction flask in one portion as a solid. A solution of 1,4-butanediol 180 (1 mL, 10 mmol) in 
THF (3 mL) was added to the stirred suspension of sodium hydride in THF. tert-
Butyldimethylsilyl chloride (1.69 g, 11.2 mmol) dissolved in THF (3 mL) was added to the 
resulting suspension of sodium hydride and stirred at room temperature overnight. The reaction 
mixture turned light yellow after stirring for overnight. The reaction mixture was quenched with 
saturated potassium carbonate (12 mL) and extracted with diethyl ether (3 x 10 mL). The 
combine organic extracts were washed with brine (15 mL), dried over sodium sulfate, filtered 
and concentrated in vacuo to afford the crude product as yellow oil. The crude product was 
purified by flash column chromatography on silica, eluting with a mobile phase of 15% EtOAc – 
hexane (2.04 g, 60% yield). 1H NMR (400 MHz, CDCl3) δ 3.67 - 3.52 (m, 4H), 2.85 (bs, OH) 
1.70 – 1.60 (m, 4H), 0.90 (s, 9H), 0.07 (s, 6H).  
4-((tert-Butyldimethylsilyl)oxy)butanal (176)  
A 250-mL oven-dried round-bottomed flask equipped with a magnetic stir bar and 
nitrogen inlet and powdered molecular sieves was charged with anhydrous dichloromethane (75 
mL). Pyridinium chlorochromate (1.94 g, 9.0 mmol) and sodium acetate (0.15 g, 1.8 mmol) were 
added to the reaction flask. To the above resulting suspension was added monoprotected 1,4-
butanediol (180) (1.23 g, 6.00 mmol) in dichloromethane (75 mL) and stirred at room 
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temperature for 36 h. Diethyl ether (30 mL) was added and the mixture was passed through a 
short pad of florisil to remove any unreacted pyridinium chlorochromate. The filtrate was then 
dried over sodium sulfate, filtered and concentrated in vacuo. The crude reaction mixture was 
purified by flash column chromatography on silica, eluting with a mobile phase of 7:3 hexane - 
diethyl ether to afford the aldehyde 176 as a colorless oil (0.76 g, 63 %). 1H NMR (400 MHz, 
CDCl3) δ 9.79 (t, J = 1.7 Hz, 1H), 3.65 (t, J = 6.0 Hz, 2H), 2.51 (td, J = 7.1, 1.7 Hz, 2H), 1.86 
(quintet, J = 7.0 Hz, 2H), 0.89 (s, 9H), 0.04 (s, 6H). 
4-((tert-Butyldiphenylsilyl)oxy)butan-1-ol (208)  
An oven-dried 100-mL round-bottomed flask equipped with a magnetic stir bar and 
nitrogen gas inlet was charged with 1,4-butanediol (179) (1.35 g, 15 mmol) and N,N-
diisopropylethylamine (2.72 mL, 15.6mmol) in anhydrous dichloromethane (5 mL).  tert-
Butyldiphenylsilyl chloride (1.3 mL, 4.95 mmol) was added dropwise to the reaction mixture and 
stirred at room temperature overnight.  The crude reaction mixture was concentrated in vacuo to 
afford yellow oil. The crude product was purified by flash column chromatography on silica, 
eluting with a mobile phase of 20% EtOAc – hexane to afford the monoprotected diol 208 as a 
clear oil (1.54 g, 95% yield). 1H NMR (400 MHz, CDCl3) δ 7.71 -7.63 (m, 4H), 7.47 - 7.34 (m, 
6H), 3.75 - 3.62 (m, 4H), 2.01 (bs, OH), 1.73 - 1.60 (m, 4H), 1.05 (s, 9H).  
4-((tert-Butyldiphenylsilyl)oxy)butanal (209)  
An oven-dried 250-mL round-bottomed flask equipped with a magnetic stir bar and 
nitrogen gas inlet was charged with anhydrous dichloromethane (20 mL) and cooled to -78 oC in 
a dry ice-acetone bath. Oxalyl chloride (0.67 mL, 7.81 mmol) followed by a solution of dimethyl 
sulfoxide (1.15 mL, 16.1 mmol) in dichloromethane (4 mL) was added to the cooled reaction 
mixture. The reaction mixture was stirred for 5 min and a solution of tert-butyldiphenylsilyl 
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chloride protected butanol XX (2.44 g, 7.44 mmol) in dichloromethane (8 mL) was added via 
syringe to the reaction mixture and the resulting suspension was stirred for 50 min at -78 oC.  
Triethylamine (5.06 mL, 36.3 mmol) was added dropwise followed by the stirring at -78 oC for 
additional 10 min. The reaction mixture was allowed to warm to room temperature and stirred 
for 3 h at room temperature. The reaction mixture was then diluted with dichloromethane, 
washed successively with 3% hydrochloric acid, water, saturated aqueous sodium bicarbonate 
and water. The organic layer was dried over sodium sulfate, filtered and concentrated in vacuo to 
yield the crude product as brown oil. The crude product was purified by flash column 
chromatography on silica, eluting with a mobile phase of 20% EtOAc – hexane to afford the 
aldehyde 209 as a colorless oil (2.30 g, 95% yield) 1H NMR (400 MHz, CDCl3) δ 9.78 (t, J = 1.7 
Hz, 1H), 7.67 - 7.62 (m, 4H), 7.45 - 7.34 (m, 6H), 3.69 (t, J = 6.1 Hz, 2H), 2.54 (td, J = 7.2, 1.7 
Hz, 2H), 1.93 – 1.84 (m, 2H), 1.05 (s, 9H). 
5-(1-hydroxyethylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione (166) 
 An oven-dried 100-mL round-bottomed flask equipped with a magnetic stir bar and 
nitrogen gas inlet was charged with Meldrums Acid (3.60 g, 25 mmol) in anhydrous 
dichloromethane (10 mL). The flask and its contents were cooled to 0 oC in an ice-water bath and 
pyridine (4.8 mL, 60 mmol) was added with stirring over a 10 min period. To the resulting clear 
solution, was added a solution of acetyl chloride (1.78 ml, 25 mmol) in dichloromethane (8 mL) 
over a 20 min period at 0 oC. After the addition was complete the resulting orange reaction 
mixture was warmed to room temperature and stirred overnight. The reaction mixture was then 
diluted with dichloromethane (10 mL) and then poured into 2N hydrochloric acid (15 mL) 
containing crushed ice. The organic layer was separated and the aqueous layer was extracted 
with dichloromethane (2 x 10 mL). The organic layers were combined and washed with 2N 
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hydrochloric acid (10 mL), brine (10 mL), dried over sodium sulfate, filtered and concentrated in 
vacuo to yield acetylated Meldrum’s Acid 166 as a pale yellow solid (3.6 g, 79% yield). 1H 
NMR (500 MHz, CDCl3) δ 2.68 (s, 3H), 1.74 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 194.6, 
170.2, 160.5, 104.9, 91.8, 26.8, 23.5. 
(S)-1-(4-Benzyl-2-oxooxazolidin-3-yl)butane-1,3-dione (167)  
An oven-dried 100 mL round-bottomed flask equipped with a magnetic stir bar, water 
condenser and nitrogen gas inlet was charged with acetylated Meldrum’s Acid 166 (1.82 g, 10 
mmol), chiral oxazolidinone 161 (1.77 g, 10 mmol) in anhydrous toluene (40 mL) and refluxed 
for 5 h. The organic layer was washed with brine (20 mL), water (20 mL) and dried over sodium 
sulfate, filtered and concentrated in vacuo to afford the crude product. The crude product was 
purified by flash column chromatography on silica, eluting with a mobile phase of 1:3 EtOAc – 
hexane to yield the β-keto imide 167 as white solid (0.83 g, 32% yield) (Rf = 0.5 in 1:1 EtOAc – 
hexane). 1H NMR (400 MHz, CDCl3) δ 7.37 - 7.27 (m, 3H), 7.26 - 7.21 (m, 2H), 4.76 - 4.68 (m, 
1H), 4.26 - 4.16 (m, 2H), 4.07 (AB, J = 2.3 Hz, 2H), 3.38 (dd, J = 13.5, 3.5 Hz, 1H), 2.80 (dd, J 
= 13.5, 9.6 Hz, 1H), 2.30 (s, 3H). 13C NMR (101 MHz, CDCl3) δ 201.2, 166.6, 153.9, 135.3, 
129.7, 129.2, 127.6, 66.6, 55.2, 51.6, 37.9, 30.4. 
(S)-3-Acetyl-4-benzyloxazolidin-2-one (169)  
An oven-dried 25 mL round-bottomed flask equipped with a magnetic stir bar, water 
condenser and nitrogen gas inlet was charged with chiral oxazolidinone (0.89 g, 5 mmol) and 
acetyl chloride (1.05 mL, 15 mmol). Pyridine (0.40 mL, 5 mmol) was added dropwise to the 
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reaction mixture and refluxed for 10 h. The reaction mixture was cooled and dichloromethane 
(50 mL) was added. The organic layer was washed with 5% hydrochloric acid (20 mL), saturated 
sodium bicarbonate (20 mL), water (20 mL) and brine (20 mL). The organic layer was dried over 
magnesium sulfate, filtered and concentrated in vacuo to yield the crude product. The crude 
product was filtered by column chromatography on silica, eluting with 1:3 EtOAc – hexane to 
afford the acylated chiral oxazolidinone 169 as a orange solid  (0.42 g, 65% yield).  1H NMR 
(400 MHz, CDCl3) δ 7.38 - 7.27 (m, 3H), 7.25 - 7.19 (m, 2H), 4.68 (m, 1H), 4.24 - 4.15 (m, 2H), 
3.31 (dd, J = 13.4, 3.4 Hz, 1H), 2.78 (dd, J = 13.4, 9.6 Hz, 1H), 2.56 (s, 3H). 13C NMR (101 
MHz, CDCl3) δ 170.5, 153.8, 135.4, 129.6, 129.2, 127.6, 66.3, 55.2, 38.0, 24.1. 
 
(S)-2-Amino-3-phenylpropan-1-ol (163)  
An oven-dried 500-mL three-necked round-bottomed flask equipped with a mechanical 
stirrer, water condenser and nitrogen gas inlet was charged with anhydrous tetrahydrofuran (250 
mL) and cooled to 0 oC in an ice-water bath. Lithium aluminum hydride (5.92 g, 156 mmol) was 
added in portion to the flask followed by slow addition of S-phenyl alanine (16.5 g, 100 mmol). 
The reaction mixture was heated to reflux for 3 h and cooled to room temperature. The excess 
lithium aluminum hydride was quenched with slow addition of potassium hydroxide (2.8 g) in 
water (15 mL). After the addition of aqueous potassium hydroxide, the reaction mixture was 
heated to reflux for 20 min. The reaction mixture was cooled and then vacuum filtered. The 
aluminum salts were washed with boiling tetrahydrofuran (2 x 50 mL). The combined filtrate 
(THF) was dried over anhydrous sodium sulfate, filtered and concentrated in vacuo to yield 
amino alcohol as a light yellow colored solid (12.3 g, 82% yield). The product was carried on 
without further purification. 1H NMR (400 MHz, CDCl3) δ 7.25 - 7.07 (m, 5H), 6.28 (bs, OH), 
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3.84 - 3.45 (m, 2H), 3.13 (dd, J = 13.6, 5.2 Hz, 1H), 3.02 - 2.61 (m, 2H). 13C NMR (101 MHz, 
CDCl3) δ 135.8, 129.5, 129.0, 127.3, 61.1, 55.2, 35.9. 
(S)-Ethyl (1-hydroxy-3-phenylpropan-2-yl)carbamate (164)  
An oven-dried 250-mL round-bottomed flask equipped with a magnetic stir bar was 
charged with amino alcohol 163 (12.3 g, 80.8 mmol), water (61 mL), sodium bicarbonate (34 g, 
404 mmol) and ethyl chloroformate (8 mL, 84.8 mmol). The reaction mixture was stirred at room 
temperature for 4 h and then extracted with ethyl acetate (4 x 40 mL). The organic extracts were 
washed with water (50 mL), brine (50 mL), dried over magnesium sulfate, filtered and 
concentrated on a rotary evaporator to yield ethyl carbamate 164 as light yellow colored solid 
(14.2 g, 78.6% yield).  The product was carried on without further purification. 1H NMR (400 
MHz, CDCl3) δ 7.34 - 7.17 (m, 5H), 5.09 (bs, 1H), 4.07 (q, J = 7.1 Hz, 2H), 3.91 (bs, 1H), 3.64 
(dd, J = 11.1, 3.9 Hz, 1H), 3.54 (dd, J = 11, 5.1 Hz, 1H) 2.99 - 2.78 (m, 3H), 1.20 (t, J = 7.1 Hz, 
3H). 13C NMR (101 MHz, CDCl3) δ 157.1, 137.9, 129.5, 128.7, 126.7, 64.1, 61.2, 54.2, 37.6, 
14.7. 
(S)-4-benzyloxazolidin-2-one (161) 
 An oven-dried 100-mL round-bottomed flask was equipped with a magnetic stir bar and 
short path distillation head. The flask was charged with ethyl carbamate (5.60 g, 25 mmol) and 
potassium carbonate (0.14 g, 1.01 mmol). The reaction was heated to 125-130 oC under reduced 
pressure (ca. 40 mmHg) until gas evolution has stopped. The reaction mixture was allowed to 
cool to room temperature to afford a brown oily solid. The crude product was recrystallized from 
1:2 EtOAc – hexanes to yield the chiral oxazolidinone as a light orange colored solid (1.86 g, 
52% yield). 1H NMR (400 MHz, CDCl3) δ 7.38 - 7.27 (m, 3H), 7.21 - 7.16 (m, 2H), 5.16 (bs, 
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1H), 4.48 (dd, J = 8.6, 8.0 Hz, 1H), 4.16 (dd, J = 8.6, 5.5 Hz, 1H), 4.13 – 4.03 (m, 1H), 2.94 - 





An oven-dried 100-mL round-bottomed flask equipped with a magnetic stir bar and 
nitrogen gas inlet was charged with anhydrous dichloromethane (9 mL) and cooled to 0 oC in an 
ice-water bath. Neat diethylzinc (0.16 mL, 1.50 mmol) was added via syringe in one portion 
followed by dropwise addition of diiodomethane (0.12 mL, 1.50 mmol) over 5 min. The reaction 
mixture was allowed to stir for 10 min at 0 oC during which time a milky white suspension was 
formed. At this time β-keto imide 175 (0.22 g, 0.50 mmol) dissolved in dichloromethane (3 mL), 
was added via syringe in one portion and allowed to stir at 0 oC for 30 min. tert-
Butyldimethylsilyl-protected aldehyde 176 (0.12 g, 0.6 mmol) was added via syringe in one 
portion to the reaction flask and stirred at 0 oC for 40 min. The reaction mixture was quenched 
with saturated ammonium chloride (6 mL) and the organic layer was separated. The aqueous 
layer was extracted with dichloromethane (3 x 5 mL). The combined organic extracts were 
washed with brine, dried over sodium sulfate, filtered and concentrated on a rotary evaporator to 
yield the crude product as an yellow oil. The crude mixture was purified by flash column 
chromatography on silica, eluting with a gradient mobile phase of 
2%,5%,7%,8%,10%,12%,15%,20%,25%,30%,35%,40% ethyl acetate in hexane  to afford the 
title compound 177 as a mixture of open-hemiacetal isomers as a yellow oil (0.23 g, 70%). It was 
not possible to identify the specific 1H NMR resonances that resulted from the ketone and 
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hemiacetal form, although the relative integration of the Ph, tBu, Si-Me and Me resonances were 
consistent with the chain extension aldol product.   1H NMR (400 MHz, CDCl3) δ 7.37 - 7.17 (m, 
5H), 4.76 - 4.61 (m, 2H), 4.51 - 4.36 (m, 1H), 4.36 - 4.09 (m, 3H), 4.05 (ddd, J = 10.3, 5.2, 3.5 
Hz, 1H), 3.99 - 3.75 (m, 2H), 3.72 – 3.57 (m, 2H), 3.40 (dd, 1H),  3.30 – 3.10 (m, 2H) 2.84 - 
2.69 (m, 2H), 2.63 - 2.43 (m, 2H), 2.36 (dd, J = 13.6, 10.2 Hz, 1H), 2.26 (dd, J = 13.6, 9.2 Hz,  
1H), 2.17 – 2.10 (m, 1H), 1.95 - 1.50 (m, 8H), 1.43 (s, OH), 1.16 (d, J = 6.2 Hz, 1.5 H) 1.15 (d, J 
= 6.1 Hz, 1.5 H), 1.11 (d, J = 6.1 Hz, 3H)  0.89 (s, 9H), 0.88 (s, 3H), 0.87 (s, 2 H), 0.06 (s, 6H), 
0.05 (s, 2H), 0.04 (s, 2H). 13C NMR (101 MHz, CDCl3) 215.3, 214.9, 181.8, 181.2, 179.8, 179.7, 
159.0, 158.8, 158.3, 141.1, 140.7, 140.2, 140.2, 134.8, 134.4, 134.3, 132.6, 132.6, 132.5, 112.3, 
111.7, 87.2, 86.3, 76.6, 74.0, 73.8, 73.0, 72.8, 71.7, 71.5, 71.3, 68.7, 68.6, 68.3, 61.1, 60.7, 53.2, 
52.8, 52.5, 49.5 49.3, 46.3, 45.5, 45.3, 45.0, 44.2, 44.0, 43.7, 43.1, 42.6, 41.8, 41.2, 39.7, 39.2, 
38.5, 37.6, 37.3, 37.2, 35.7, 34.8, 34.6, 34.4, 31.3, 31.3, 29.2, 29.1, 28.6. Evidence of hemiacetal 
in the 13C resonances at 112.3 and 111.7 ppm and evidence of ketone isomer at peaks 215.3 and 
214.9 ppm.  
(S)-1-(Phenoxycarbonyl) pyrrolidine-2-carboxylic acid (286) 
An oven-dried 100-mL round-bottomed flask equipped with a rubber septum, magnetic 
stir bar was charged with L-proline (2.9 g, 25 mmol) in aqueous sodium carbonate (0.75 M, 6.9 g 
in 87 mL water). The reaction flask was cooled to 0 oC in an ice-water bath to which the phenyl 
chloroformate (3.14 mL, 25 mmol) was added in a dropwise fashion over 3 min via syringe. The 
reaction mixture was warmed to room temperature and stirred overnight. The reaction mixture 
was then washed with ethyl acetate (2 x 50 mL) and the aqueous layer was acidified to pH 1 
using concentrated HCl (ca. 15 mL). The acidified aqueous layer was extracted with ethyl 
acetate (4 x 75 mL). The organic layers were combined, dried over sodium sulfate and 
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concentrated in vacuo to yield the crude product as an yellow oily residue. Diethyl ether (3 x 25 
mL) was added to the crude oily residue, sonicated and then removed on the rotary evaporator to 
yield the 286 as a white crystalline solid (5.26 g, 89.6%) (m.p. 93.4 – 95.5 oC) (Rf = 0.26; 1:1 
hexane: ethyl acetate);  1H NMR (400 MHz, CDCl3) δ 10.89 (s, 1H), 7.40 – 7.05 (m, 5H) 4.47 
(dd, J = 8.5, 3.8 Hz, 1H), 3.82 - 3.47 (m, 2H), 2.42 - 1.89 (m, 4H).  13C NMR (101 MHz, CDCl3) 
mixture of rotameric forms δ 177.75, 176.82, 153.55, 152.58, 150.71, 128.93, 125.16, 121.33, 
59.05, 58.73, 46.77, 30.63, 29.33, 24.06, 23.13.  IR (neat) ν 2972, 2668, 1657, 1411, 1196, 1162 
cm-1. 
4-(Dimethylamino)pyridin-1-ium(S)-(2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)(1-
(phenoxycarbonyl)pyrrolidin-2-yl)methanolate (287)  
 An oven-dried 250-mL round-bottomed flask equipped with a rubber septum, magnetic 
stir bar and nitrogen gas inlet was charged with anhydrous dichloromethane (15 mL) and cooled 
to 0 oC in an ice-water bath. Phenyl carbamate protected L-proline 286 (1.90 g, 8 mmol) 
dissolved in dry dichloromethane (10 mL) was added to the reaction flask. 
Dicyclohexylcarbodiimide (1.65 g, 8 mmol), Meldrums acid (1.15 g, 8 mmol) and N,N’-
dimethylaminopyridine (0.98 g, 8 mmol) were added in the indicated order as solids in one 
portion to the reaction mixture at 0 oC. The reaction mixture turned yellow on the addition of  
N,N’-dimethyaminopyridine. The reaction mixture was allowed to stir at room temperature for 
12 h at which time the reaction mixture was filtered to remove N,N’-dicyclohexylurea byproduct 
and then concentrated on a rotary evaporator to yield an foamy yellow solid. The crude solid was 
dissolved in miminal amount of ethyl acetate, diluted with diethyl ether and concentrated in 
vacuo three times to afford the title  compound 287 as an fluffy yellow solid (3.61 g, 88%) (m.p. 
66 – 70 oC). The product was carried on without further purification. 1H NMR (500 MHz, 
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CDCl3) mixture of rotameric forms δ 8.23 (d, J = 7.5 Hz, 2H), 7.34 - 6.92 (m, 5H), 6.56 (d, J = 
7.5 Hz, 2H), 5.75 (dd, J = 8.8, 3.4 Hz, 1H), 3.87 - 3.53 (m, 2H), 3.14 (s, 6H), 2.60 - 2.48 (m, 
1H), 2.09 - 1.97 (m, 1H), 1.96 -1.84 (m, 2H), 1.77 (s, 1H), 1.65 (s, 6H). 13C NMR (126 MHz, 
CDCl3) mixture of rotameric forms δ 196.05, 194.90, 166.32, 156.92, 153.75, 153.09, 151.58, 
140.94, 128.99, 128.89, 128.75, 124.67, 124.43, 121.91, 121.61, 106.32, 101.14, 100.97, 87.24, 
65.02, 47.93, 39.86, 31.60, 31.03, 27.50, 26.28, 23.79, 23.04. IR (neat) ν 2953, 1715, 1640, 
1598, 1556, 1492, 1442, 1378, 1318, 1261, 1198, 1160 cm-1.   
(S)-phenyl 2-(3-oxo-3-(2-oxooxazolidin-3-yl)propanoyl)pyrrolidine-1-carboxylate  (289) 
 An oven-dried 250-mL round-bottomed flask equipped with a rubber septum, magnetic 
stir bar and nitrogen gas inlet was charged with DMAP salt XX (3.86 g, 8 mmol) and DOWEX 
50W-X2 ion exchange resin (12 g, 1.5 g of DOWEX for 1 mmol of DMAP salt) in anhydrous 
dichloromethane (20 mL) and stirred at room temperature for 3 h. The resin was removed by 
filtration and filtrateconcentrated on a rotary evaporator to afford the crude free acid 288 (2.41 g, 
6.67 mmol) as a yellowish gummy solid, which was then dried on high vacuum line overnight.  
 An oven-dried 250-mL round-bottomed flask equipped with a rubber septum, magnetic 
stir bar and nitrogen gas inlet was charged with free acid 288 (2.41 g, 6.67 mmol) and 2-
oxazolidone (0.64 g, 7.33 mmol) in anhydrous toluene (150 mL). The reaction mixture was 
refluxed for 5 h and monitored by TLC. The reaction mixture was then cooled to room 
temperature and then washed with water (50 mL) and brine (50 mL). The organic layer was then 
dried over sodium sulfate, filtered and concentrated on a rotary evaporator to yield the crude title 
compound 289 as a yellow viscous oil. The crude product was purified by flash column 
chromatography on silica, eluting with 50% ethyl acetate in hexane (Rf = 0.1, 1:1 
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hexane:ethylacetate) to afford the title compound as a white crystalline solid (1.73 g, 75%) (m.p. 
52.4 – 53.8 oC), as a mixture of carbamate rotamers and also keto-enol isomers. 
1H NMR (400 MHz, CDCl3) major keto tautomer δ 7.40 – 7.30 (m, 2H), 7.22 – 7.07 (m, 3H), 
4.65 (dd, J = 8.0, 5.1 Hz, 1H), 4.46 – 4.38 (m, 2H), 4.25 (AB, 2H), 4.12 - 4.01 (m, 2H), 3.80 - 
3.59 (m, 2H), 2.40 - 1.90 (m, 4H). 13C NMR (101 MHz, CDCl3) mixture of keto-enol and 
rotameric forms δ 202.83, 202.53, 166.50, 166.38, 153.89, 152.91, 151.34, 151.11, 129.50, 
125.72, 125.63, 121.84, 65.60, 65.42, 62.50, 48.54, 47.70, 47.57, 42.48, 29.84, 28.67, 24.68, 
23.73. IR (neat) ν 3340, 2980, 1773, 1696, 1593, 1570, 1492, 1476, 1455, 1385, 1364, 1338, 
1303, 1196, 1162, 1119 cm-1. 
(S)-phenyl 2-((1S,5S)-3-oxo-2-oxabicyclo[3.1.0]hexan-1-yl)pyrrolidine-1-carboxylate (290) 
and (S)-phenyl 2-((1R,5R)-3-oxo-2-oxabicyclo[3.1.0]hexan-1-yl)pyrrolidine-1-carboxylate 
(291) 
An oven-dried 100-mL round bottomed flask equipped with a magnetic stir bar and 
nitrogen gas inlet was charged with anhydrous dichloromethane (30 mL) and cooled to 0 oC in an 
ice-water bath. Diethylzinc (0.60 mL, 5.77 mmol) was added to the reaction mixture via syringe 
at 0 oC and allowed to stir for 5 min. Diiodomethane (0.92 mL, 11.5 mmol) was added to the 
solution dropwise via syringe over a 5 min period and the reaction mixture was stirred at 0 oC for 
15 min. β-keto imide 289 (0.4 g, 1.15 mmol) dissolved in anhydrous dichloromethane (10 mL) 
was added to the milky white suspension via syringe and then allowed the reaction mixture to stir 
at room temperature for 3 h. The progress of the reaction was monitored by thin layer 
chromatography. The reaction was then quenched with saturated ammonium chloride (15 mL). 
The organic layer was separated, washed with water (15 mL), brine (15 mL), dried over 
anhydrous sodium sulfate and concentrated via rotary evaporation to afford a 2.5 : 1 mixture of 
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diastereomers as a yellow oil. The crude residue was purified by flash column chromatography 
on silica, eluting with a gradient mobile phase of 2%, 4%, 6%, 8%, 10%, 12%, 14%, 16%, 18%, 
20%, 22%, 24%, 26%, 28%, 30%, 32%, 34%, 36%, 38%, 40% ethyl acetate in hexane (Rf = 0.42 
1:1 Hexane : ethyl acetate) to afford the title compound 290, the major diastereomer, as a 
mixture of carbamate rotamers, as an yellow oil ( 0.108 g, 33% yield).  
1H NMR (400 MHz, C6D6) Major diastereomer (290) δ 7.29 - 6.87 (m, 5H), 3.49 - 3.19 (m, 3H), 
2.53 (dd, J = 18.6, 6.9 Hz, 1H), 1.94 (d, J = 18.5 Hz, 1H), 1.88 – 1.73 (m, 2H), 1.54 – 1.44 (m, 
1H), 1.40 - 1.18 (m, 2H), 0.31 (t, J = 7.9 Hz, 1H), 0.03 (t, J = 6.2 Hz, 1H).  13C NMR (101 MHz, 
C6D6) δ 175.3, 153.3, 152.1, 129.3, 125.2, 122.1, 68.6, 60.3, 47.9, 33.4, 29.5, 24.0, 17.4, 17.2. IR 
(neat) ν 2360, 2341, 2159, 1977, 1772, 1493, 1455, 11359, 1200, 1165, 1100, 1059.  Minor 
diastereomer (291) (Rf = 0.38, 1:1 Hexane: ethylacetate) 1H NMR (400 MHz, C6D6) δ 7.25 – 
6.90 (m, 5H), 3.80 (d, J = 8.6 Hz, 1H), 3.37 - 3.31 (m, 1H), 3.30 - 3.20 (m, 1H), 2.18 (dd, J = 
18.6, 6.8 Hz, 1H), 1.87 (d, J = 18.7 Hz, 1H), 1.82 – 1.70 (m, 1H), 1.66 - 1.56 (m, 2H), 1.50 – 
1.39 (m, 1H), 1.17 (t, J = 8.9 Hz, 1H), 0.69 (t, J = 7.9 Hz, 1H), 0.26 (t, J = 6.1 Hz, 1H). 13C NMR 




carboxylate (292) and (S)-phenyl 2-((1R,2R)-2-(2-(benzylamino)-2-oxoethyl)-1-
hydroxycyclopropyl)pyrrolidine-1-carboxylate (293) 
 An oven-dried 10 mL round-bottomed flask equipped with a magnetic stir bar and 
nitrogen gas inlet was charged with lactones containing mostly major diastereomer 290 and some 
minor diastereomer 291 (86 mg, 0.30 mmol) in benzylamine (200 µL, 1.5 mmol). The reaction 
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mixture was stirred at room temperature overnight. Ethyl acetate (3 mL) was added and washed 
with 2 N HCl (3 x 5 mL). The ethyl acetate layer was separated, dried over sodium sulfate, 
filtered and concentrated on a rotary evaporator to yield the crude reaction mixture containing 
both major and minor diastereomers as an yellow oil. The crude reaction mixture was purified by 
preparative thin layer chromatography, eluting four times with 30% methyl tert-butyl ether in 
hexane (140 mL) by adding 10 mL of methanol each time to the above eluting solvent containing 
30% MTBE in hexane (Rf = 0.19, 1:1 hexane:ethyl acetate) to afford the title compound 292 , the 
major diastereomer containing carbamate rotamers as a white solid (0.086 g, 73% overall yield). 
1H NMR (400 MHz, C6D6) δ 7.37 - 7.28 (m, 2H), 7.14 - 6.85 (m, 8H), 5.95 (s, NH), 4.39 (dd, J = 
14.6, 6.3 Hz, 1H), 3.97 (dd, J = 14.6, 5.4 Hz, 1H), 3.71 – 3.63 (m, 1H), 3.58 - 3.45 (m, 1H), 3.33 
(dd, J = 8.8, 3.5 Hz, 1H), 2.23 (d, J = 4.5 Hz, 1H), 2.19 - 2.02 (m, 3H), 1.72 - 1.50 (m, 2H), 1.46 
- 1.33 (m, 2H), 0.57 - 0.48 (m, 2H).  13C NMR (126 MHz, C6D6) δ 173.5, 153.9, 152.5, 139.0, 
129.1, 128.6, 128.5, 127.3, 124.9, 122.6, 65.5, 59.6, 48.3, 43.7, 36.8, 29.2, 24.5, 23.1, 18.1. IR 
(neat) ν 3330, 2972, 1780, 1715, 1647, 1594, 1538, 1454, 1383, 1160, 1061, 1024. 
(S)-Phenyl2-((1R,2R)-2-(2-(benzylamino)-2-oxoethyl)-1-hydroxycyclopropyl)pyrrollidine-1-
carboxylate  
  The minor diastereomer existing of its carbamate rotamers was obtained as a white solid 
(Rf  = 0.21, 1:1 hexane:ethyl acetate). 1H NMR (400 MHz, C6D6) δ 7.37-7.17 (m, 2H), 7.14 - 
6.85 (m, 8H), 5.75 (t, J = 6.1 Hz, NH), 4.46 - 4.17 (m, 2H), 3.94 – 3.79 (m, 1H), 3.46 - 3.37 (m, 
1H), 3.22 – 3.04 (m, 1H), 2.27 – 2.15 (tt, J = 9.2, 4.5 Hz, 0H), 1.48 - 1.25 (m, 6H), 1.15 - 0.88 
(m, 4H), 0.80 - 0.70 (m, 1H). 13C NMR (101 MHz, C6D6) δ 176.17, 155.50, 152.02, 139.82, 
129.51, 128.72, 128.62, 127.28, 125.55, 122.31, 65.27, 60.07, 48.42, 43.41, 40.06, 28.85, 24.51, 
24.06, 18.54, 18.12. 
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 N-Benzyl-2-((1S,2S,7a'S)-3'-oxotetrahydro-3'H-spiro[cyclopropane-1,1'-pyrrolo[1,2-
c]oxazol]-2-yl)acetamide (297) 
An oven-dried 10 mL round-bottomed flask equipped with a magnetic stir bar and 
nitrogen gas inlet was charged with cyclopropanol amide 290 (34 mg, 0.08 mmol) in anhydrous 
tetrahydrofuran (3 mL) and cooled to 0 oC in an ice-water bath. Potassium t-butoxide (24 mg, 
0.21 mmol) was added as a solid in portions to the reaction mixture, upon which the solution 
turned yellow. The reaction mixture was stirred at 0 oC for 50 min. Water (2 mL) was added and 
the reaction mixture was extracted with ethyl acetate (3 x 5 mL), organic layers were combined, 
dried over sodium sulphate, gravity filtered and concentrated invacuo to yield the crude reaction 
mixture as an oil. The crude reaction mixture was purified by preparative thin layer 
chromatography, eluting with 50 % ethyl acetate in hexane (Rf = 0.11, 1 : 1 hexane : ethyl 
acetate) and obtained as a white solid (22 mg, 90% yield  ). 1H NMR (500 MHz, C6D6) δ 7.20 - 
7.03 (m, 5H), , 6.15 (bs, NH), 4.30 (AB, J = 14.9, 5.9 Hz, 2H), 3.45 (dt, J = 11.3, 7.9 Hz, 1H), 
2.99 (dd, J = 9.8, 5.8 Hz, 1H), 2.72 (ddd, J = 11.2, 9.3, 3.9 Hz, 1H), 2.28 - 2.04 (m, 2H), 1.38 - 
1.24 (m, 2H), 1.13 – 1.03 (m, 1H), 1.01 - 0.95 (m, 1H), 0.92 – 0.80 (m, 1H) 0.59 (t, J = 7.1 Hz, 
1H), 0.52 (dd, J = 10.1, 7.1 Hz, 1H). 13C NMR (126 MHz, C6D6) δ 171.6, 160.7, 129.8, 128.7, 
128.6, 127.3, 66.5, 64.7, 46.4, 43.7, 34.8, 29.0, 25.2, 20.1, 12.8. IR neat  ν 3316, 2916, 1722, 
1672, 1540, 1496, 1420, 1363, 1211,1076. 
(S)-phenyl 2-(3-((S)-4-benzyl-2-oxooxazolidin-3-yl)-3-oxopropanoyl)pyrrolidine-1-
carboxylate (298) 
An oven-dried 250-mL round-bottomed flask equipped with a rubber septum, magnetic 
stir bar and nitrogen gas inlet was charged with free acid 286 (1.30 g, 3.61 mmol) and chiral 
oxazolidinone (0.70 g, 3.97 mmol) in anhydrous toluene (150 mL). The reaction mixture was 
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refluxed for 5 h and monitored by TLC. The reaction mixture was then cooled to room 
temperature and then washed with water (50 mL) and brine (50 mL). The organic layer was dried 
over sodium sulfate, filtered and concentrated on a rotary evaporator to yield the crude title 
compound 298 as yellow viscous oil. The crude product was purified by flash column 
chromatography on silica, eluting with 25% ethyl acetate in hexane (Rf = 0.1, 1:1 
hexane:ethylacetate) to afford the title compound 298 as a white crystalline solid (1.18 g, 75% 
yield) (m.p. 131.2 – 133.1 oC), as a mixture of carbamate rotamers and also keto-enol isomers. 
1H NMR (500 MHz, CDCl3) δ 7.40 - 7.26 (m, 5H), 7.24 - 7.09 (m, 5H), 4.76 - 4.64 (m, 2H), 4.35 
(dd, J = 16.9, 4.5 Hz, 1H), 4.23 - 4.13 (m, 3H), 3.78 - 3.58 (m, 2H), 3.40 – 3.32 (m, 1H), 2.84 – 
2.72 (m, 1H), 2.38 – 2.26 (m, 1H), 2.23 - 2.13 (m, 1H), 2.02 - 1.92 (m, 2H). 13C NMR (126 MHz, 
CDCl3) δ 202.6, 202.4, 166.3, 166.2, 153.8, 153.7, 152.8, 151.2, 151.0, 135.2, 135.1, 129.5, 
129.5, 129.3, 129.3, 129.3, 129.0, 129.0, 127.4, 127.4, 125.5, 125.5, 66.5, 66.1, 65.5, 65.3, 55.1, 
48.7, 47.9, 47.5, 47.4, 37.7, 30.4, 29.6, 28.4, 24.5, 23.5. 
 
(S)-phenyl2-(2-((1R,2S)-2-((S)-4-benzyl-2-oxooxazolidin-3-yl)-2-
((trimethylsilyl)oxy)cyclopropyl)acetyl)pyrrolidine-1-carboxylate (299)  
An oven-dried 100-mL round bottomed flask equipped with a magnetic stir bar and 
nitrogen gas inlet was charged with anhydrous dichloromethane (20 mL) and cooled to 0 oC in an 
ice-water bath. Neat diethylzinc (0.14 mL, 1.40 mmol) was added in one portion via an oven-
dried needle followed by dropwise addition of diiodomethane (0.23 mL, 2.80 mmol) over the 
course of 5 min. The reaction was allowed to stir at 0 oC for 10 min at which time a milky white 
suspension was formed. Trimethylsilyl chloride (0.04 mL, 0.31 mmol) followed by β-keto imide 
298 (0.12 g, 0.28 mmol) dissolved in dichloromethane (6 mL) was added to the reaction mixture. 
	   152	  
The reaction mixture was allowed to stir at 0 oC for 30 min and then allowed to warm to room 
temperature. The reaction mixture was allowed to stir at room temperature for 5 h. The crude 
reaction mixture was quenched with saturated ammonium chloride (10 mL). The layers were 
separated and the aqueous layer was extracted with dichloromethane (3 X 15 mL). All the 
organic layers were combined and washed with brine, dried over sodium sulfate, filtered and 
concentrated in vacuo. The crude reaction mixture was purified by preparative thin layer 
chromatography where the plate was first eluted with 10% ethyl acetate in hexane (180 mL). 
Additional amount of ethyl acetate (35 mL) was added to the above eluting solvent to increase 
the polarity and the plate was eluted again to afford 299  (0.09 g, 62% yield) (Rf = 0.42; 1:1 
EtoAc: Hexane) as a mixture of diastereomers in a diastereomeric ratio of 5:1. Major 
diastereomer and its rotamer 1H NMR (500 MHz, C6D6) δ 7.42 - 7.33 (m, 3H), 7.23 - 7.17 (m, 
3H), 7.16 - 6.83 (m, 10H), 4.30 (dd, J = 8.5, 5.5 Hz, 1H), 4.25 – 4.20 (m, 1H), 4.05 -3.96 (m, 
2H), 3.71 (dt, J = 8.8, 3.9 Hz, 1H), 3.58 (dd, J = 12.9, 3.7 Hz, 1H), 3.53 - 3.48 (m, 1H), 3.48 - 
3.37 (m, 3H), 3.37 - 3.26 (m, 3H), 2.70 (dd, J = 18.4, 3.3 Hz, 1H), 2.63 - 2.57 (m, 1H), 2.52 - 
2.42 (m, 1H), 2.42 - 2.33 (m, 2H), 2.27 – 2.20 (m, 1H), 1.64 - 1.49 (m, 4H), 1.48 – 1.34 (m, 3H), 
1.33 – 1.26 (m, 2H), 1.24 - 1.09 (m, 3H), 0.99 - 0.89 (m, 1H), 0.80 – 0.74 (m, 2H), 0.28 (s, 9H), 
0.22 (s, 6H). 13C NMR (126 MHz, C6D6) δ 209.0, 208.8, 156.0, 155.9, 153.2, 152.5, 152.0, 
151.80, 137.5, 137.1, 130.1, 129.9, 129.4, 129.3, 129.0, 128.9, 127.1, 126.9, 125.3, 121.8, 121.8, 
66.6, 66.5, 66.4, 66.1, 66.1, 58.0, 47.7, 47.3, 40.7, 40.7, 37.5, 37.1, 30.2, 28.9, 24.5, 23.6, 22.3, 
22.1, 18.9, 18.7, 1.07, 1.00. 
TBAF rearrangement of TMS cyclopropanol (299) 
An oven-dried 100 mL round bottomed flask equipped with a magnetic stir bar and 
nitrogen gas inlet was charged with TMS cyclopropanol 299 (25.4 mg, 0.05 mmol) in anhydrous 
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THF (5 mL). Tetra-n-butylammonium fluoride (1M in THF) (0.05 mL, 0.05 mmol) was added to 
the reaction mixture and stirred at room temperature overnight. The reaction mixture was 
quenched with saturated ammonium chloride and the layers were separated. The aqueous layer 
was extracted with diethyl ether (3 X 5 mL). The ether extracts were combined, dried over 
sodium sulfate, filtered and concentrated in vacuo. The crude reaction mixture was purified using 
preparative thin layer chromatography. The plate was eluted with 20% ethyl acetate in hexane to 
yield the bicyclic lactone 290. δ 7.29 - 6.87 (m, 5H), 3.49 - 3.19 (m, 3H), 2.53 (dd, J = 18.6, 6.9 
Hz, 1H), 1.94 (d, J = 18.5 Hz, 1H), 1.88 – 1.73 (m, 2H), 1.54 – 1.44 (m, 1H), 1.40 - 1.18 (m, 
2H), 0.31 (t, J = 7.9 Hz, 1H), 0.03 (t, J = 6.2 Hz, 1H).  13C NMR (101 MHz, C6D6) δ 175.3, 




An oven-dried 250-mL round bottomed flask equipped with a rubber septum, magnetic 
stir bar and nitrogen gas inlet was charged with free acid 288 (2.91 g, 8.05 mmol) and chiral 
oxazolidinone derived from R-phenylalanine (1.57 g, 8.86 mmol) in anhydrous toluene (150 
mL). The reaction mixture was refluxed for 5 h and monitored by TLC. The reaction mixture 
was then cooled to room temperature and then washed with water (50 mL) and brine (50 mL). 
The organic layer was then dried over sodium sulfate, filtered and concentrated on a rotary 
evaporator to yield the crude title compound 301 as yellow viscous oil. The crude product was 
purified by flash column chromatography on silica, eluting with 50% ethyl acetate in hexane (Rf 
= 0.1, 1:1 hexane:ethylacetate) to afford the title compound 301 as a white crystalline solid  (m.p. 
132.5 – 134.8 oC), as a mixture of carbamate rotamers and also keto-enol isomers. 1H NMR (400 
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MHz, CDCl3) δ 7.39 - 7.26 (m, 5H), 7.25 - 7.09 (m, 5H), 4.76 – 4.64 (m, 2H), 4.35 (dd, J = 16.8, 
11.5 Hz, 1H), 4.25 - 4.14 (m, 3H), 3.85 - 3.61 (m, 2H), 3.41 (ddd, J = 13.0, 9.0, 3.4 Hz, 1H), 
2.86 - 2.72 (m, 1H), 2.42 - 1.91 (m, 4H). 13C NMR (101 MHz, CDCl3)  mixture of rotamers δ 
203, 202.7, 166.3, 154.0, 152.9, 151.3, 151.1, 135.5, 135.3, 129.6, 129.5, 129.2, 127.6, 127.5, 
125.7, 125.6, 121.8, 88.3, 88.2, 66.6, 66.2, 65.6, 65.4, 60.6, 60.5, 55.3, 48.9, 48.1, 47.7, 47.5, 
37.8, 30.9, 29.8, 28.7, 24.7, 24.3, 23.7. 
(S)-phenyl2-(2-((1S,2R)-2-((R)-4-benzyl-2-oxooxazolidin-3-yl)-2-
((trimethylsilyl)oxy)cyclopropyl)acetyl)pyrrolidine-1-carboxylate (302)  
An oven-dried 100-mL round bottomed flask equipped with a magnetic stir bar and 
nitrogen gas inlet was charged with anhydrous dichloromethane (20 mL) and cooled to 0 oC in an 
ice-water bath. Neat diethylzinc (0.24 mL, 2.30 mmol) was added in one portion via an oven-
dried needle followed by dropwise addition of diiodomethane (0.37 mL, 4.60 mmol) over the 
course of 5 min. The reaction was allowed to stir at 0 oC for 10 min at which time a milky white 
suspension was formed. Trimethylsilyl chloride (0.05 mL, 0.51 mmol) followed by β-keto imide 
301 (0.20 g, 0.46 mmol) dissolved in dichloromethane (15 mL) was added to the reaction 
mixture. The reaction mixture was allowed to stir at 0 oC for 30 min and then allowed to warm to 
room temperature. The reaction mixture was allowed to stir at room temperature for 5 h. The 
crude reaction mixture was quenched with saturated ammonium chloride (20 mL). The layers 
were separated and the aqueous layer was extracted with dichloromethane (3 X 20 mL). All the 
organic layers were combined and washed with brine, dried over sodium sulfate, filtered and 
concentrated in vacuo. The crude reaction mixture was purified by preparative thin layer 
chromatography where the plate was first eluted with 10% ethyl acetate in hexane (180 mL). 
Additional amount of ethyl acetate (35 mL) was added to the above eluting solvent to increase 
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the polarity and the plate was eluted again to afford the TMS cyclopropanol 302 as a mixture of 
diastereomers in a diastereomeric ration of 5:1. Major diastereomer and its rotamer 1H NMR 
(500 MHz, C6D6) δ 7.42 - 7.38 (m, 2H), 7.37 - 7.33 (m, 1H), 7.25 (m, 3H), 7.20 - 7.15 (m, 6H), 
7.14 - 7.02 (m, 5H), 6.95 - 6.90 (m, 2H), 4.33 (dd, J = 8.3, 3.9 Hz, 1H), 4.26 (dd, J = 8.0, 4.6 Hz, 
1H), 4.10 – 3.98 (m, 2H), 3.76 – 3.71 (m, 2H), 3.65 - 3.53 (m, 2H), 3.53 - 3.48 (m, 1H), 3.42 (dd, 
J = 12.8, 3.5 Hz, 1H), 3.39 - 3.33 (m, 2H), 3.29 (dt, J = 10.2, 7.4 Hz, 1H), 2.64 (dd, J = 18.7, 3.2 
Hz, 1H), 2.48 (dd, J = 12.8, 11.0 Hz, 2H), 2.32 (dd, J = 18.7, 3.2 Hz, 1H), 2.20 – 2.07 (m, 2H), 
1.70 - 1.50 (m, 6H), 1.49 – 1.40 (m, 1H), 1.32 - 1.16 (m, 4H), 0.75 (td, J = 6.8, 2.3 Hz, 2H), 0.26 
(s, 9H), 0.25 (s, 6H). 13C NMR (126 MHz, C6D6) δ 208.5, 208.4, 156.0, 156.0, 153.2, 152.5, 
152.2, 152.1, 137.2, 137.0, 130.0, 130.0, 129.4, 129.3, 129.0, 129.0, 128.3, 127.1, 127.0, 77.8, 
66.5, 66.1, 66.0, 64.8, 58.0, 58.0, 55.6, 47.5, 47.2, 40.8, 40.7, 39.3, 38.5, 29.7, 28.7, 24.2, 23.1, 
22.1, 22.1, 18.8, 18.8, 1.07, 1.05, 0.83, 0.74. 
TBAF rearrangement of TMS cyclopropanol (302) 
An oven-dried 100 mL round bottomed flask equipped with a magnetic stir bar and 
nitrogen gas inlet was charged with TMS cyclopropanol 302 (25.4 mg, 0.05 mmol) in anhydrous 
THF (5 mL). Tetra-n-butylammonium fluoride (1M in THF) (0.05 mL, 0.05 mmol) was added to 
the reaction mixture and stirred at room temperature overnight. The reaction mixture was 
quenched with saturated ammonium chloride and the layers were separated. The aqueous layer 
was extracted with diethyl ether (3 X 5 mL). The ether extracts were combined, dried over 
sodium sulfate, filtered and concentrated in vacuo. The crude reaction mixture was purified using 
preparative thin layer chromatography. The plate was eluted with 20% ethyl acetate in hexane to 
yield the bicyclic lactone 291. 1H NMR (400 MHz, C6D6) δ 7.25 – 6.90 (m, 5H), 3.80 (d, J = 8.6 
Hz, 1H), 3.37 - 3.31 (m, 1H), 3.30 - 3.20 (m, 1H), 2.18 (dd, J = 18.6, 6.8 Hz, 1H), 1.87 (d, J = 
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18.7 Hz, 1H), 1.82 – 1.70 (m, 1H), 1.66 - 1.56 (m, 2H), 1.50 – 1.39 (m, 1H), 1.17 (t, J = 8.9 Hz, 
1H), 0.69 (t, J = 7.9 Hz, 1H), 0.26 (t, J = 6.1 Hz, 1H). 13C NMR (101 MHz, C6D6) δ 174.8, 
157.0, 153.5, 129.3, 125.2, 122.0, 68.7, 59.5, 47.3, 33.2, 28.5, 24.1, 19.5, 13.5. 
(2S)-phenyl-2-(2-(2-(2-oxooxazolidin-3-yl)-2-
((trimethylsilyl)oxy)cyclopropyl)acetyl)pyrrolidine-1-carboxylate (320) 
An oven-dried 250-mL round bottomed flask equipped with a rubber septum, magnetic 
stir bar and nitrogen gas inlet was charged with free acid 319 (0.50 g, 1.26 mmol) and chiral 
oxazolidinone derived from R-phenylalanine (0.23 g, 1.33 mmol) in anhydrous toluene (25 mL). 
The reaction mixture was refluxed for 5 h and monitored by TLC. The reaction mixture was then 
cooled to room temperature and then washed with water (15 mL) and brine (15 mL). The organic 
layer was then dried over sodium sulfate, filtered and concentrated on a rotary evaporator to 
yield the crude title compound XX as yellow viscous oil. The crude product was purified by 
flash column chromatography on silica, eluting with 20% ethyl acetate in hexane (Rf = 0.1, 1:1 
hexane:ethylacetate) to afford the title compound 320 as a cream colored solid (0.26 g, 45% 
yield) (m.p. = 68.2 – 69.7 oC) 1H NMR (500 MHz, CDCl3) δ 7.75 – 7.71 (m, 2H), 7.41 - 7.21 (m, 
7H), 4.80 – 4.72 (m, 1H), 4.52 (AB, 2H), 4.26 (td, J = 8.5, 2.4 Hz, 1H), 4.22 – 4.16 (m, 2H), 
3.60 – 3.50 (m, 1H), 3.42 – 3.33 (m, 1H), 3.30 – 3.20 (m, 1H), 2.82 (ddd, J = 12.6, 9.5, 2.5 Hz, 
1H), 2.45 (s, 3H), 2.29 - 2.20 (m, 1H), 1.92 – 1.82 (m, 1H), 1.68 - 1.49 (m, 2H). 13C NMR (126 
MHz, CDCl3) δ 204.0, 166.8, 153.7, 144.2, 135.2, 133.5, 129.9, 129.5, 129.0, 127.8, 127.3, 67.3, 
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